Interim / Quarterly Report • Sep 15, 2021
Interim / Quarterly Report
Open in ViewerOpens in native device viewer
| 1. | STATEMENTS BY MEMBERS OF THE BOARD OF DIRECTORS 4 | |||
|---|---|---|---|---|
| 2. | SEMI-ANNUAL BOARD OF DIRECTORS' MANAGEMENT REPORT 6 | |||
| 2.1 | INTRODUCTION 6 | |||
| 2.2 | PERFORMANCE AND FINANCIAL POSITION 6 | |||
| 2.3 | SIGNIFICANT EVENTS DURING THE 1ST HALF OF 2021 8 | |||
| 2.4 | MAJOR RISKS AND UNCERTAINTIES FOR THE 2nd HALF OF 2021 11 | |||
| 2.5 | FUTURE OUTLOOK AND PROSPECTS 13 | |||
| 2.6 | RELATED PARTY TRANSACTIONS 14 | |||
| 2.7 | Information concerning the acquired Treasury Shares according to article 50, paragraph 2, Law 4548/2018. 17 | |||
| 2.8 | SUBSEQUENT EVENTS 17 | |||
| 2.9 | ALTERNATIVE PERFORMANCE MEASURES ("APMs") 17 | |||
| 3. | REPORT ON REVIEW OF THE INTERIM FINANCIAL INFORMATION20 | |||
| 4. | INTERIM CONDENSED FINANCIAL STATEMENTS 22 | |||
| 4.1 | STATEMENT OF FINANCIAL POSITION 23 | |||
| 4.2 | INTERIM CONDENSED ITEMS OF THE STATEMENT OF INCOME 24 | |||
| 4.3 | INTERIM CONDENSED STATEMENT OF CHANGES IN GROUP'S EQUITY FOR THE PERIOD 25 | |||
| 4.4 | INTERIM CONDENSED STATEMENT OF CHANGES IN COMPANY'S EQUITY FOR THE PERIOD 26 | |||
| 4.5 | INTERIM CONDENSED STATEMENT OF CASH FLOWS 27 | |||
| 4.6 | NOTES ON THE INTERIM CONDENSED FINANCIAL STATEMENTS 28 | |||
| 4.6.1 | The Company 28 | |||
| 4.6.2 | Group Structure 28 | |||
| 4.7 | BASIS FOR THE PREPARATION OF THE FINANCIAL STATEMENTS 29 | |||
| 4.7.1 | Compliance with IFRS 29 | |||
| 4.7.2 | Basis for the preparation of the financial statements29 | |||
| 4.7.3 | Approval of financial statements 29 | |||
| 4.7.4 | Covered Period29 | |||
| 4.7.5 | Presentation of the financial statements29 | |||
| 4.7.6 | Significant judgments and estimations by Management29 | |||
| 4.7.7 | Significant Accounting Policies31 | |||
| 4.8 | FINANCIAL RISK MANAGEMENT 32 | |||
| 4.8.1 | Capital Management32 | |||
| 4.8.2 | Financial Instruments33 | |||
| 4.8.3 | Definition of fair values33 | |||
| 4.9 | EXPLANATORY NOTES ON THE FINANCIAL STATEMENTS 34 | |||
| 4.9.1 | Segment Reporting34 | |||
| 4.9.2 | Investments in associate companies36 | |||
| 4.9.3 | Goodwill 36 | |||
| 4.9.4 | Inventories 36 | |||
| 4.9.5 | Trade and other receivables37 | |||
| 4.9.6 | Cash & cash equivalents39 | |||
| 4.9.7 | Financial Assets at Fair Value through Results39 | |||
| 4.9.8 | Trade and other liabilities 39 | |||
| 4.9.9 | Provisions and other long-term liabilities 40 | |||
| 4.9.10 | Loans 41 |
| 4.9.11 | Income tax41 | |
|---|---|---|
| 4.9.12 | Financial Income / Expenses 41 | |
| 4.9.13 | Share Capital 42 | |
| 4.9.14 | Earnings per Share 42 | |
| 4.9.15 | Dividends42 | |
| 4.9.16 | Treasury Shares42 | |
| 4.9.17 | Table of changes in fixed assets43 | |
| 4.9.18 | Number of Employees49 | |
| 4.9.19 | Litigation Cases49 | |
| 4.9.20 | Contingent Liabilities49 | |
| 4.9.21 | Contractual Obligations49 | |
| 4.9.22 | Events after the Balance Sheet Date49 | |
| 4.9.23 | Related party transactions50 | |
| 4.9.24 | Business Units and Geographical Analysis Tables53 | |
It is hereby declared that to our knowledge:
a) The Semi-Annual Condensed Financial Statements (Parent and Consolidated) of the company "GR. SARANTIS S.A." for the period from 1 January 2021 to 30 June 2021, which were prepared according to the International Financial Reporting Standards (IFRS) that were adopted by the European Union and specifically based on the International Accounting Standard (IAS) 34 "Interim Financial Reporting", accurately present the assets and liabilities, equity and results for the aforementioned period of the Company as well as those of the companies included in the consolidation, considered as a whole, according to the provisions of paragraphs 3 to 5 of article 5, Law 3556/2007.
b) The Semi-Annual Report of the Board of Directors reflects in a true manner the information required according to the paragraph 6 of article 5 of Law 3556/2007, namely the significant events that took place during the first half of the fiscal year and their effect on the semi-annual financial statements, the development, performance and financial position of the Company as well as of the businesses included in the Group consolidation, considered as a whole, including the description of the principal risks and uncertainties for the second half of the fiscal year, and also the significant transactions that concerned the Company and the businesses included in the consolidation, and furthermore the transactions with the related parties.
Marousi, September 8 th 2021 The Members of the Board
| THE CHAIRMAN OF THE BOARD | MANAGING DIRECTOR | THE GROUP'S CHIEF FINANCIAL OFFICER & BOARD MEMBER |
||
|---|---|---|---|---|
| GRIGORIS SARANTIS | KYRIAKOS SARANTIS | KONSTANTINOS ROZAKEAS | ||
| ID NO. Χ 080619/03 | ID NO. ΑΙ 597050/2010 | ID NO. ΑΚ 783631/13 |
SEMI-ANNUAL REPORT OF THE BOARD OF DIRECTORS FOR THE PERIOD 01.01.2021 – 30.06.2021
The present report of the Board of Directors of "GR. SARANTIS S.A." (henceforth the "Company") has been compiled according to the provisions of article 5 of Law 3556/2007 as well as to the relevant decisions of the Board of Directors of the Hellenic Capital Market Commission and refers to the Interim Condensed financial statements (Consolidated and Separate) of 30th June 2021 and of the semi-annual period that ended on the above date.
The Report is included in the semi-annual financial report of the period 1.1.2021 - 30.06.2021, together with the Company's financial statements and other information and statements required by law.
The present report briefly presents the Company's financial information for the first half of the year 2019, significant events that occurred during the above mentioned period and their effects on the semi-annual financial statements. The report also includes a description of the basic risks and uncertainties the Group's companies may face during the second half of the current year. Finally, significant transactions between the issuer and its related parties are also presented.
The semi-annual separate and consolidated financial statements have been compiled according to the International Financial Reporting Standards (IFRS) which were adopted by the European Union and specifically based on the International Accounting Standard (IAS) 34 "Interim Financial Reporting".
The current Report also presents the Alternative Performance Measures in paragraph 2.9.
The Group's total turnover during H1 2021 reached €195.24 million from € 183.69 million in H1 2020, up by 6.29%, underpinned by the Group's ability to address different consumption patterns and channel dynamics in each country. Throughout the first half of 2021 sales were driven by all product categories related to home care and personal care, while the gradual reopening of the market in combination with higher consumer traffic, benefited the categories of fragrances, deodorants and suncare.
• Greece, presented sales of €69.25 million in H1 2021 compared to €67.64 mil. in H1 2020, up by 2.38%, with the mass market channel driving the growth and the Luxury Cosmetics gaining momentum following the reopening of the market and the increased consumption in the respective channel.
• The foreign countries, exhibited growth of 8.56% reaching €125.99 million in H1 2021 from €116.05 million in H1 2020.
The Group's profitability in H1 2021 benefited by tight control of gross profit and balanced operating expenses, while controlled advertising and promotion expenses were reactivated and allocated behind strategic initiatives.
• EBT settled at €24.71 mil. in H1 2021 from €19.63 mil. in H1 2020, increased by 25.89%, with the EBT margin reaching 12.66% from 10.69% in the previous year's first half.
• Net Profit reached €19.51 mil. in H1 2021 from €15.62 mil. in the previous year's first half, up by 24.90%, while Net Profit margin settled at 9.99% from 8.50% in H1 2020.
The Group exhibits a healthy financial position supported by the improving profitability of the business, and balanced capital expenditure.
Despite the challenges posed by the COVID-19 pandemic, the Group, committed to its strategy, invests the cash generated by the business behind initiatives to accelerate growth, either organically or through acquisitions, and to return value to its shareholders.
Within 2021, the Group paid a dividend for FY 2020 of approximately €15 mil. (0.22393 euros per share), increased by 34% compared to last year's dividend payment.
As of the first half of 2021 the Group's net debt over EBITDA ratio stood at 0.54x, with a net debt position reaching €35.38 mil., from € 10.91 mil as of the end of 2020, as a result of the dividend payment and investments that are largely related to the construction of Polipak's new production facility as well as machinery equipment at Oinofyta's production plant.
Polipak's new garbage bags production plant will lead to a more automated production process, which, combined with a new R&D and new equipment, will result in higher production capacity, increased efficiency and products improved in terms of ecological profile, durability and functionality.
As part of its strategy to further grow sales and profits organically, emphasis is given in optimizing the Group's product portfolio, leveraging the strong brand equity within its strategic product categories. Targeted investments and innovation plans will be allocated behind strategic product development initiatives in order to drive further growth across our territory.
Moreover, investments relating to infrastructure, systems, processes, and models have been enabled in order to increase further the Group's efficiency and effectiveness.
Regarding sales breakdown per business unit, Personal Care products sales were up by 8.02% yoy to €85.09 mil. in H1 2021 from €78.11 mil. in H1 2020, supported by growth in the own brands portfolio, that increased by 12.22%. This performance reflects the continued strong demand in categories related to personal hygiene, such as face care, body care, body wash and wand wash, while the gradual reopening of the market benefited categories such as fragrances, deodorants and suncare. The category's participation to total Group turnover amounted to 43.58%.
Sales of Home Care increased by 6.22% amounting to €76.13 million from €71.67 million in the previous year's first half, supported by the own brands subcategory, and in particular driven by all product categories related to home care. The category's participation to total Group turnover amounted to 38.99%.
The category "Private Label" represents sales of Polipak, the Polish packaging products company, which specializes on the production of private label garbage bags. Sales of this category exhibited a 5.33% increase in H1 2021 amounting to €11.45 mil. from €10.87 mil. in H1 2020.
The category of Other Sales was up in sales by 0.84%, driven by the Luxury Cosmetics category that presented a 3.28% sales growth as a result of the reopening of the market and increased consumption within this channel.
Regarding operating profits per business unit, Personal Care products EBIT settled at €5.85 million from €5.05 million in the first half of the previous year, up by 15.92%, driven by the own Personal Care products subcategory that presented an EBIT growth of 22.84%. The margin of Personal Care products stood at 6.88% in H1 2021.
The EBIT of Home Care products posted an increase of 12.20% during H1 2021 to €9.56 million from €8.52 million in H1 2020, driven by the own brands subcategory that was up by 11.50%. The EBIT margin of the Home Care products stood at 12.56% during H1 2021 from 11.89% in H1 2020 and their participation to total Group EBIT settled at 38.41% in H1 2021.
The EBIT of the Other Sales category was up by 2.03% to € 2.04 mil. from € 2.00 mil., driven by the Luxury Cosmetics subcategory.
The income from Associated Companies represents the income from the Estee Lauder JV that stood at €6.35 mil. up by 23.25% vs last year's first half, as a result of the re-opening of the market and increased consumption within this channel.
Regarding turnover breakdown by geographical region, Greece, presented sales of €69.25 million in H1 2021 compared to €67.64 mil. in H1 2020, up by 2.38%, with the mass market channel driving the growth and the Luxury
Cosmetics gaining momentum following the reopening of the market and the increased consumption in the respective channel.
The foreign countries, representing 64.53% of the Group's total sales, exhibited growth of 8.56% reaching €125.99 million in H1 2021 from €116.05 million in H1 2020.
Throughout the first half of 2021 and across the Group's region sales were driven by all product categories related to home care and personal care, while the gradual reopening of the market in combination with higher consumer traffic, benefited the categories of fragrances, deodorants and suncare.
Regarding operating profits per geographical region, the Greek EBIT during H1 2021 increased by 19.27% to €15.49 mil., from €12.99 mil. in H1 2020.
Excluding the income from Associated companies, Greek EBIT during H1 2021 amounted to €9.14 mil. up by 16.66% compared to €7.83 mil. last year's first half. Greek EBIT margin, excluding income from Associated Companies, stood at 13.20% during FY 2020 from 11.58% in H1 2020.
The foreign countries EBIT was up by 1.52% during H1 2021, amounting to €9.41 mil. from 9.27 mil. In the first half of last year. The foreign countries EBIT margin settled at 7.47% from 7.99% in H1 2020.
It is noted that:
Read the resolutions of the Extraordinary General Shareholders Meeting of February 24th 2021.
Read the resolutions of the Ordinary General Shareholders Meeting of May 20th 2021.
The BoD's term is 5 years, that is until May 19th 2026, automatically extended until the end of the term, within which period the next regular general meeting must convene after the end of its term and until the relevant decision is taken, and it is not possible to exceed six years.
❖ Following the decision of the Annual General Meeting of the Company's Shareholders, which was held on May 20th, regarding the appointment of the Audit Committee, the Audit Committee was formed into body on May 28th 2021.
Following:
It is noted that the Audit Committee is an independent committee, since it consists of two independent nonexecutive members of the Board of Directors and a third person, and has a term starting from its election until the Ordinary General Meeting to be convened in 2022.
❖ Following the General Shareholders Meeting resolution dated May 20th 2021, the company GR. SARANTIS S.A. announced the distribution of dividend payment for the fiscal year 2020 amounting to 0.214661421 euro per share.
According to the legislation in force, the dividend corresponding to the company's 2,891,424 treasury shares was applied to the dividend paid out to the other shareholders and hence the dividend was increased to 0.22392718 euro per share.
The aforementioned dividend amount was subject to a 5% withholding tax and therefore shareholders received a net amount of 0,212730821 euro per share.
May 25th 2021 was set as the ex-dividend date, while the entitled shareholders were those registered in the Dematerialized Securities System on May 26th 2021 (Record date).
The dividend payment took place on May 31st 2021.
❖ On 26/05/2021, 10% of IVYBRIDGE was acquired by the Company, therefore the Group now owns 100% of both the direct participation of IVYBRIDGE, as well as the indirect participation in the subsidiaries ERGOPACK and HOZTORG.
The exponential COVID-19 spread and its declaration by WHO as a pandemic, is an unexpected global challenge with an uncertain course.
The Group responded with flexibility and sensitivity, supported by its people, despite the continuous challenges across the Group's countries.
Sarantis Group, with an utmost sense of responsibility, closely monitors the recent developments and responds appropriately at all levels, having prepared a specific coronavirus action plan, according to the evolution of the pandemic across its geographical region.
Since the beginning of the COVID-19 outbreak, set out its key priorities:
Since the beginning of 2020, when the virus started to spread worldwide, the Group enacted a special management team and precautionary measures in line with each state's government in which it operates and in accordance with the official WHO's guidelines.
In Greece, a special coronavirus protection policy was enacted which includes remote working, suspension of both professional and personal travel, cancellation of both internal and external events, the headquarters' decontamination and special health guidance. In the other countries of its operation, the Group aligned with the precautionary measures taken by the authorities and implemented remote work and further specific protection measures.
Since then, the Group maintains safety and hygiene measures across its facilities and adapts according to the restrictive measures imposed by governments and relevant authorities in the countries of its operation, as the pandemic is still evolving.
In addition, the Group's contribution to the society was intensified during the pandemic, focusing on strengthening the health sector and supporting those in need in the Group's countries, through product and monetary donations, as well as donations in-kind to hospitals, nursing homes, NGOs and other socially vulnerable groups.
Moreover, during the quarantine period, we offered internally information on the pandemic and health & wellbeing promotion services [eg. healthy nutrition habits within the quarantine, alternative proposals of leisure entertainment like seminars, online theaters, online books, online tours, etc].
• Implementing contingency and business continuity plans in order to safeguard production plants and enable the Group's supply chain to remain fully operational in order to ensure the uninterrupted business continuity and the continuous supply of high-demand products to the market.
As the needs of the consumers turned to specific product categories, the Group ensured its ability to respond to increased demand for specific product categories, such as home care and personal hygiene products as well as food supplements.
In addition, the Group entered into the production of antibacterial products, in the hand cleansing category, in order to meet the high demand for these products.
• Maintenance of financial resilience and implementation of the Group's strategic plan in order to support the Group's further growth.
Amidst this extraordinary environment, and as the Group's priorities remained focused on the health & safety of its employees and the society and its uninterrupted business continuity, the Group managed to maintain a solid
financial position and free cashflow generation, while executing its investment plan and creating further value to all stakeholders.
During the first half of 2021, investments realized relate to new product development, upgrading machinery equipment, expanding production capacity, while a dividend payment was done to the shareholders of the Company.
The Group's agility and ability to respond to unpredictable consumption trends, increased demand for certain product categories, and deal with unprecedent challenges posed by the COVID-19 crisis, is reflected in the Group's robust H1 2021 performance which is characterized by increased sales, increase in earnings and strong cashflow generation.
Specifically, the Group's turnover and net profit increased by 6.29% and 24.90%, respectively, in H1 2021 compared to the previous year's first half, and the Group's cash and cash equivalents amounted to € 23.2 million. The only activity affected during the first half of 2021 due to the pandemic is that of luxury cosmetics, as the clients of this channel were in lockdowns frequently throughout the year. Nevertheless, the increased consumption following the reopening of this channel resulted in luxury cosmetics sales growth of 3.28% and EBIT growth of 22.78% during the first half of 2021
Regarding the receivables from the luxury cosmetics customers, and although the extension of the check repayment to 75 days was used, until today there is a normal flow of collection.
Even though the operating environment across our region has improved within the first half of 2021, it still remains volatile, particularly considering the resurgence of COVID-19 cases and the rapid spread of the Delta variant. Occasional closures and restrictions will most likely continue within the year, affecting daily life and therefore consumption trends. Nevertheless, we are encouraged by our resilient performance within the first half of 2021, our strong financial position and cashflow generation, that provide safety and the support necessary to mitigate any potential negative impact arising from the pandemic. The management will stay focused on tits long-term goals in order to bring further top line growth, further improvement on profit margins and cashflow generation.
The Group is exposed to financial and other risks, including the unforeseen changes in interest rates, credit risks and liquidity risks. The Group's overall risk management program aims at minimizing the possible negative effects from such risks on its financial performance. The Group's financial instruments consist mainly of deposits with banks, trade accounts receivable and payable, loans and dividends payable.
The Group operates in an environment characterized by relatively high foreign exchange risk given that almost 65% of the Group's total turnover comes from Eastern European countries where the volatility of foreign exchange rates is likely to be high. The management of the Group is constantly examining the currencies' fluctuations, but at the moment it has not taken any measures against the foreign exchange risk due to the lack of appropriate hedging tools.
The interest rate risk emerges from the relation between the cost of debt and the subsequent effect of any interest rate changes on the earnings and cash flows. The Group's objective is to achieve an optimal balance between borrowing cost and the potential effect of any interest rate changes on earnings and cash flows. The Group monitors and manages its debt and overall financing strategies using a combination of short and long-term debt. It is policy of the Group to continuously review interest rate trends along with its financing needs. Daily working capital requirements are typically financed with operational cash flow and through the use of various committed lines of credit. The interest rate on these short-term borrowing arrangements, is generally determined as the inter-bank offering rate at the borrowing date plus a pre-set margin. The mix of fixed-rate debt and variable-rate debt is managed within Group policy guidelines.
Credit risk is the risk that a counterparty will cause the Group and the Company to suffer a financial loss because of the obligation to settle the liabilities. The maximum credit risk to which the Group and the Company are exposed at the date of the preparation of the financial statements is the book value of their financial assets.
Financial assets classified as at fair value through profit or loss are viewed not to expose the Group and the Company to material credit risk.
The greater part of the risk is found in the event that the debtor - customer of the Group may default on contractual obligations resulting in material loss to the Group. The Group's receivables come from wholesale, while a large part of its receivables come from large customers. The financial position of the customers is continuously monitored by the Group companies, which both control the amount of credit provisions and the credit limits of the accounts and, on the other hand, try to effectively manage the receivables before they become overdue but also when they become overdue or doubtful. Where necessary, additional collateral is required with guarantees.
In order to monitor credit risk, customers are grouped according to the category they belong to, their credit risk characteristics, the maturity of their receivables and any previous problematic receivables that they have demonstrated, taking into account future factors as well as the economic environment.
The Group and the Company apply the simplified approach of IFRS 9 for the calculation of expected credit losses and recognize impairment losses for expected credit losses for all financial assets other than those measured at fair value through profit or loss.
During the year and despite the COVID-19 pandemic, the flow of receivables from clients is normal, as the Group's main distribution network is the mass market channel, which remained in full and even increased operation due to increased consumer needs. In addition, the health care network was fully operational, which means that more than 90% of the Group's sales remain unaffected by operating suspensions.
Specifically, regarding customers who have used the 75-day check repayment extension, the Company still receives all receivables. These customers relate to the luxury cosmetics network in Greece, which is periodically suspended, while the sales of this network represent less than 10% of the total sales of the Group.
The liquidity risk refers to a case when the Group is not in position to fulfill its obligations with regard to money payments. Prudent liquidity risk management implies the existence of a balance between cash flows as well as funding through adequate amounts of committed credit facilities. The Group closely monitors the amount of funding as well as the short-term and long-term funding with respect to total debt and the composition of total debt, and it manages the risk that could arise from the lack of sufficient liquidity and secures that necessary borrowing facilities are maintained. The Group has sufficient credit line facilities that could be utilized to fund any potential shortfall in cash resources.
The Group manages and monitors its working capital in order to minimize any possible liquidity and cash flow risks.
The Group is exposed to price volatility in the basic raw materials it uses for products that manufactures in its own production facilities.
❖ The basic raw materials used by the Group for the Perfume, Cosmetics and Face Care products are perfumes, oils and chemicals.
The prices of raw materials in perfumes, cosmetics and facials present fluctuations, and any differences are eliminated by gradually transferring volumes from one supplier to another when necessary, maintaining active alternative suppliers and creating security stocks.
❖ The basic raw materials used by the Group for the categories of household products (food packaging products and plastic waste bags) are aluminum (in jumbo rolls), plastic (PVC / LDPE Clingfilm in Jumbo rolls) and polyethylene (HDPE, LDPE, LLDPE).
Regarding the effect of fluctuations in the prices of aluminum and plastic, the Group proceeds to the closing of price at short intervals, and in addition creates a security stock when it deems it necessary.
The incomplete compliance with the legal regulatory framework that governs the Group could lead to penalties and other fines, so by this way it will negatively affect the financial position and, as a result its reputation. Regulatory compliance issues that are recognized by the management are as follows:
Issues related to commercial legislation
Taxation and labor issues
Issues related to the Capital Market Committee and the Stock Exchange
Issues related to the protection of personal data
Issues covered by the Code of Ethics (fraud, bribery, child labor, work safety and work practices, issues relating to free competition, etc.)
Issues relating to the protection of the environment and the operation of the production facilities.
Issues relating to product safety and certification (e.g. EFET) where provided, as well as to the protection of consumers.
The relevant body that is responsible for assessing the risks is the Execution Committee. Each group of risks shall be examined separately. The likelihood of occurrence, the potential effect and the level of the organization's abundance are estimated, and then the optimum actions are being proposed. Subsequently the Group assigns the personnel responsible for the management who implement the agreed actions and inform the administration about the results of these actions.
The COVID-19 pandemic has led to an unprecedented crisis in global health and the economy. The Group responded immediately at all levels, through a specific coronavirus action plan, in accordance with the evolution of the pandemic across its geographical region.
Since the beginning of the COVID-19 outbreak, the Group had set out its key priorities concerning the health & safety of its employees and the society, the uninterrupted business continuity and the continuous supply of high-demand products to the market.
Since the beginning of 2020, when the virus started to spread worldwide, the Group enacted a special management team and precautionary measures in line with each state's government in which it operates and in accordance with the official WHO's guidelines.
In addition, the Group's contribution to the society was intensified during the pandemic, focusing on strengthening the health sector and supporting those in need in the Group's countries.
The Group implemented contingency and business continuity plans in order to safeguard production plants and enable the Group's supply chain to remain fully operational in order to ensure the uninterrupted business continuity and the continuous supply of high-demand products to the market.
While the outlook for the global economy in 2021 remains uncertain and the vaccination process is in process, the management is encouraged by the Group's resilient performance, its strong financial position and cashflow generation.
Furthermore, the Group's basic distribution channel is the mass retail market has remained in full operation throughout this period.
The Group's strong capital base, low net debt and strong cash flows, provide safety and the support necessary to mitigate any potential negative impact, enabling it to continue as a going concern.
Even though the operating environment across our region has improved within the first half of 2021, it still remains volatile, particularly considering the resurgence of COVID-19 cases and the rapid spread of the Delta variant. Occasional closures and restrictions will most likely continue within the year, affecting daily life and therefore consumption trends.
Nevertheless, the Group's resilient performance within the first half of 2021, itsstrong financial position and cashflow generation, provide safety and the support necessary to mitigate any potential negative impact arising from the pandemic.
Within this context, the management will continue to pursue its long-term goals in order to bring further top line growth, further improvement on profit margins and cashflow generation, supporting this way the business and returning value to its shareholders. The Group's strategy remains unchanged with the focus being, as always, on
organic and acquisitive growth, new strategic partnerships, geographical expansion, cost efficiencies, economies of scale, benefits from synergies and operating leverage.
Throughout this period, and until a gradual return to normality is achieved, the management's priorities will continue to concern the health and safety of the Group's employees and the society, the uninterrupted business continuity and continuous supply of high-demand products to the market, and the maintenance of a strong financial position.
The Group's strong financial performance is giving the management drive to continue playing an active role towards supporting the local communities, addressing emerging societal needs, particularly relating to COVID-19, and operating in an environmentally responsible way, as the Group's ultimate aim is to maintain the optimum balance between its economic performance and its responsible environmental and social practices.
The further development of the Group's sustainability strategy is amongst the top priorities of the Group's newly elected Board of Directors, addressing its four main pillars: sustainable production and consumption, responsible governance, empowered employees and thriving communities.
Business practices such as creating employment, investing in human capital development, safeguarding occupational health, safety and well-being, improving consumers health & well-being, minimizing greenhouse gas emissions, enhancing sustainable sourcing and improving waste management are amongst the areas where the Group will intensify its efforts in order to maximize the positive economic, social and environmental impacts of its operation.
The most significant transactions between the Company and its related parties, as such are defined by International Accounting Standard 24, are presented below.
| Subsidiaries | Company | ||||
|---|---|---|---|---|---|
| Trade receivables | 30.06.2021 | 31.12.2020 | |||
| Sarantis Belgrade D.O.O | 39,750 | 88,281 | |||
| Sarantis Banja Luca DOO | 0 | 197 | |||
| Sarantis Skopje D.O.O | 0 | 245 | |||
| Sarantis Bulgaria LTD | 157,023 | 153,617 | |||
| Sarantis Romania S.A. | 799,271 | 582,200 | |||
| Sarantis Polska S.A. | 884,047 | 723,296 | |||
| Sarantis Czech Republic sro | 1,297,134 | 1,422,939 | |||
| Polipak SP.Z.O.O. | 6,414 | 47,530 | |||
| Sarantis Slovakia S.R.O | 156,089 | 320,150 | |||
| Ergopack LLC | 1,092,792 | 1,108,875 | |||
| Sarantis Hungary Kft. | 113,218 | 303,954 | |||
| Sarantis Portugal Lda | 595,831 | 1,119,722 | |||
| Elode France SARL | 28,480 | 27,734 | |||
| Total | 5,170,050 | 5,898,740 |
| Trade Liabilities | 30.06.2021 | 31.12.2020 |
|---|---|---|
| Sarantis Belgrade D.O.O | 2,020,204 | 1,067,589 |
| Sarantis Banja Luca DOO | 4,251 | 5,648 |
| Sarantis Skopje D.O.O | 1,033,479 | 301,140 |
| Sarantis Bulgaria LTD | 17,108 | 0 |
| Sarantis Romania S.A. | 80,748 | 10,687 |
| Sarantis Polska S.A. | 425,791 | 629,875 |
| Sarantis Czech Republic sro | 18,525 | 0 |
| Polipak SP.Z.O.O. | 753,921 | 321,052 |
| Sarantis Slovakia S.R.O | 4,252 | 0 |
| Ergopack LLC | 61,699 | 470 |
| Sarantis Hungary Kft. | 11,532 | 10,626 |
| Sarantis Portugal Lda | 744 | 0 |
| Sarantis France SARL | 48,200 | 48,960 |
| Total | 4,480,454 | 2,396,047 |
| Liabilities from loans | 30.06.2021 | 31.12.2020 |
| Sarantis Bulgaria LTD | 6,751,855 | 7,501,237 |
| Sarantis Romania S.A. | 13,503,711 | 15,002,474 |
| Sarantis Polska S.A. | 6,751,855 | 7,501,237 |
| Waldeck LTD | 559,194 | 558,255 |
| Total | 27,566,616 | 30,563,203 |
Grand Total Liabilities 32,047,069 32,959,250
Income
| Income from sale of merchandise | 01.01 - 30.06.2021 | 01.01 - 30.06.2020 |
|---|---|---|
| Sarantis Belgrade D.O.O | 1,004,745 | 1,353,981 |
| Sarantis Skopje D.O.O | 267,476 | 358,324 |
| Sarantis Bulgaria LTD | 845,471 | 968,681 |
| Sarantis Romania S.A. | 2,883,377 | 3,645,733 |
| Sarantis Polska S.A. | 3,927,582 | 3,904,976 |
| Sarantis Czech Republic sro | 2,279,745 | 1,658,030 |
| Sarantis Slovakia S.R.O | 929,323 | 428,420 |
| Ergopack LLC | 529,042 | 662,119 |
| Sarantis Hungary Kft. | 244,492 | 331,088 |
| Sarantis Portugal Lda | 355,733 | 387,868 |
| Total | 13,266,985 | 13,699,221 |
| Income – Interest | 01.01 - 30.06.2021 | 01.01 - 30.06.2020 |
| Ergopack LLC | 0 | 53,849 |
| Total | 0 | 53,849 |
| Other Income | 01.01 - 30.06.2021 | 01.01 - 30.06.2020 |
|---|---|---|
| Sarantis Belgrade D.O.O | 88,953 | 99,059 |
| Sarantis Banja Luca DOO | 4,251 | 2,249 |
| Sarantis Skopje D.O.O | 10,772 | 9,018 |
| Sarantis Bulgaria LTD | 17,481 | 11,727 |
| Sarantis Romania S.A. | 41,791 | 41,038 |
| Sarantis Polska S.A. | 264,445 | 122,452 |
| Sarantis Czech Republic sro | 74,123 | 38,905 |
| Polipak SP.Z.O.O. | 30,716 | 14,345 |
| Sarantis Slovakia S.R.O | 31,406 | 13,938 |
| Ergopack LLC | 78,581 | 120,705 |
| Sarantis Hungary Kft. | 31,727 | 39,188 |
| Sarantis Portugal Lda | 27,081 | 32,609 |
| Total | 701,328 | 545,234 |
| Grand Total Income | 13,968,314 | 14,298,303 |
| Purchases of Merchandise - Services | 01.01 - 30.06.2021 | 01.01 - 30.06.2020 |
|---|---|---|
| Sarantis Belgrade D.O.O | 0 | 6,938 |
| Sarantis Romania S.A. | 49,732 | 7,355 |
| Sarantis Polska S.A. | 868,115 | 877,614 |
| Sarantis Czech Republic sro | 399 | 6,829 |
| Polipak SP.Z.O.O. | 1,491,492 | 2,056,495 |
| Sarantis Slovakia S.R.O | 1,424 | 0 |
| Ergopack LLC | 0 | 2,736 |
| Total | 2,411,162 | 2,957,967 |
| Expenses – Interest | 01.01 - 30.06.2021 | 01.01 - 30.06.2020 |
| Sarantis Bulgaria LTD | 70,626 | 93,844 |
| Sarantis Romania S.A. | 141,251 | 188,006 |
| Sarantis Polska S.A. | 70,626 | 94,279 |
| Waldeck LTD | 10,939 | 11,000 |
| Total | 293,441 | 387,128 |
| Grand Total Expenses | 2,704,603 | 3,345,094 |
| Table of Disclosures of Related Parties | |||||||
|---|---|---|---|---|---|---|---|
| Group Company |
|||||||
| a) Income | 0 | 13,968,314 | |||||
| b) Expenses | 0 | 2,704,603 | |||||
| c) Receivables | 0 | 5,170,050 | |||||
| d) Liabilities | 0 | 32,047,069 | |||||
| e) Transactions and remuneration of senior executives and management | 1,686,693 | 1,686,693 | |||||
| f) Receivables from senior executives and management | 84,778 | 84,778 | |||||
| g) Liabilities towards senior executives and management | 0 | 0 | |||||
| h) Receivables from affiliates | 178 | 178 | |||||
| i) Liabilities to affiliates | 0 | 0 |
During the first half of 2021, the Company proceeded to the purchase of 67,429 treasury shares at an average purchase price of 8.96 euro per share, paying 604,210 euro.
Including the 2,825,995 treasury shares already held by the company as of 31/12/2021, the Company holds in total 2,893,424 treasury shares with nominal value of EUR 0.78 per share and an average purchase price of 4.82 euro per share, having paid a total of 13,934,604 euro.
The treasury shares that the Company holds correspond to 4.14% of its share capital.
ELCA is a joint venture that was created in 2001 for the sale and distribution of beauty products in Greece, Romania, Bulgaria and Cyprus. ELCA is currently owned by Sarantis Group, which holds a 49% interest in the joint venture and EL Europe which holds the remaining 51% interest.
ELCA is based in Cyprus and fully owns the subsidiary companies ESTEE LAUDER HELLAS S.A. Cosmetics Distribution, ΕSTEE LAUDER BULGARIA EOOD and ESTEE LAUDER ROMANIA Srl., based in Greece, Bulgaria and Romania respectively.
Based on the amended Shareholders Agreement, EL Europe has the right to increase its interest in ELCA to 100% by purchasing shares held by the Group, including the right to increase its stake based on the financial statements of ELCA at June 30th 2021, June 30th 2024 and June 30th 2027 for 9%, 25% and 15% respectively.
The Group's strategy with respect to ELCA remains unchanged and is based on two factors:
1) utilizing the liquidity that will be created during the period 2021-2027 behind acquisitions that satisfy the Group's criteria and are able to provide synergies and contribute to profitability;
2) absorbing new distribution agreements that will further strengthen the Group's product portfolio.
As always, the management's goal is to execute its investment plan, focusing on its strategic product categories, geographical expansion and cost efficiencies, ultimately creating further value to its shareholders.
❖ During July 16th 2021, the Extraordinary General Shareholders' Meeting of "GR. SARANTIS S.A." took place, with the sole item on the agenda being the approval of the Suitability Policy for the BoD members according to article 3. paragraph 3 of the law 4706/2020.
Read the resolutions of the Extraordinary General Shareholders Meeting of July 16th 2021.
The Group utilizes Alternative Performance Measures (APM) in the context of its decision making with regard to the financial, operational and strategic planning as well as for the evaluation and public disclosure of its performance. These APMs serve and facilitate the best understanding of the financial and operating results of the Group, its financial position and the statement of cash flows. The Alternative Performance Measures (APMs) should be always taken into consideration along with the financial results which have been prepared in accordance with the IFRS whereas in no case they replace IFRS.
The Group utilizes the following profitability ratios for the purpose of the full analysis of its operating results:
EBITDA is calculated from the annual financial statements as follows: "Gross operating earnings" plus "Other operating income" minus the "Administrative Expenses" and the "Distribution Expenses" prior to depreciation and amortization. The depreciation and amortization for the Group are presented in the paragraph "Table of Changes in Fixed Assets" of the financial statements.
| (Euro million) | H1 2021 | H1 2020 |
|---|---|---|
| Gross operating earnings | 73.20 | 68.01 |
| Other operating income | 6.64 | 5.85 |
| Administrative expenses | 9.73 | 9.29 |
| Distribution expenses | 45.21 | 42.31 |
| Depreciation and amortization | 6.42 | 6.18 |
| Earnings before interest, taxes, depreciation and amortization |
31.32 | 28.44 |
EBIT equals with the operating earnings of the Group as they are recorded in the annual financial statements.
EBT equals with the earnings deriving before the deduction of taxes from the annual financial statements.
It equals with the earnings after the deduction of taxes as they are recorded in the financial statements. These earnings are distributed to the shareholders of the parent company.
For all the above profitability figures, the corresponding profit margin is calculated by dividing each figure with the total turnover.
| (Euro million) | H1 2021 Margin |
H1 2020 Margin |
||||
|---|---|---|---|---|---|---|
| EBITDA | Earnings before interest, taxes, depreciation and amortization |
31.32 | 16.04% | 28.44 | 15.48% | |
| EBIT | Earnings before interest and taxes | 24.90 | 12.75% | 22.26 | 12.12% | |
| EBT | Earnings before taxes | 24.71 | 12.66% | 19.63 | 10.69% | |
| Net Income | Net Earnings | 19.51 | 9.99% | 15.62 | 8.50% |
The net debt comprises a figure which depicts the capital structure of the Group. It is calculated by adding the longterm loans and the short-term loans then by deducting the cash and cash equivalents and other financial assets, such as the "Financial Assets at fair value through results", since they are considered to be liquid items. The relevant calculations are presented in the following table:
| (Euro million) | H1 2021 | FY 2020 |
|---|---|---|
| Long-term loans | 50.92 | 48.61 |
| Short-term loans | 13.86 | 7.81 |
| Cash and cash equivalents | 23.19 | 40.60 |
| Other financial assets | 6.21 | 4.91 |
| Net Debt | 35.38 | 10.91 |
Marousi, September 8 th 2021
The Board of Directors
THE CHAIRMAN OF THE BOARD MANAGING DIRECTOR THE GROUP'S CHIEF FINANCIAL OFFICER & BOARD MEMBER
GRIGORIS SARANTIS KYRIAKOS SARANTIS KONSTANTINOS ROZAKEAS
ID NO. Χ 080619/03 ID NO. ΑΙ 597050/2010 ID NO. ΑΚ 783631/13
To the Board of Directors of "GR. SARANTIS S.A."
We have reviewed the accompanying interim condensed separate and consolidated statement of financial position of "GR. SARANTIS S.A." as at 30 June 2021 and the related condensed separate and consolidated statements of comprehensive income, changes in equity and cash flows for the six-month period then ended, as well as the selected explanatory notes that comprise the interim condensed financial information, which is an integral part of the six-month financial report as required by the Law 3556/2007.
Management is responsible for the preparation and presentation of this interim condensed financial information in accordance with the International Financial Reporting Standards as adopted by the European Union and applied to Interim Financial Reporting (International Accounting Standard "IAS 34"). Our responsibility is to express a conclusion on this interim condensed financial information based on our review.
We conducted our review in accordance with International Standard on Review Engagements 2410, "Review of Interim Financial Information Performed by the Independent Auditor of the Entity". A review of interim financial information consists of making inquiries, primarily of persons responsible for financial and accounting matters, and applying analytical and other review procedures. A review is substantially less in scope than an audit conducted in accordance with International Standards on Auditing, as incorporated into the Greek Legislation and consequently does not enable us to obtain assurance that we would become aware of all significant matters that might be identified in an audit. Accordingly, we do not express an audit opinion.
Based on our review, nothing has come to our attention that causes us to believe that the accompanying interim condensed financial information is not prepared, in all material respects, in accordance with IAS 34.
Our review has not revealed any material inconsistency or misstatement in the statements of the members of the Board of Directors and the information of the six-month Board of Directors Report, as defined in articles 5 and 5a of Law 3556/2007, in relation to the accompanying interim condensed financial information.
BDO Certified Public Accountant S.A. 449 Mesogion Av, Athens- Ag. Paraskevi, Greece Reg. SOEL: 173
Ag. Paraskevi, September 9, 2021 Certified Public Accountant
Christoforos I. Achiniotis Reg. SOEL: 35961
Those responsible for the preparation of the Interim Financial Statements of the period 01/01 – 30/06/2021 are the signatories at the end of the Financial Statements.
| Group Note |
Company | ||||
|---|---|---|---|---|---|
| Amounts in € | 30.06.2021 | 31.12.2020 | 30.06.2021 | 31.12.2020 | |
| ASSETS | |||||
| Non-current assets | 195,092,031 | 183,401,276 | 185,434,234 | 181,918,424 | |
| Tangible fixed assets | 4.9.17 | 87,298,505 | 73,343,011 | 40,862,048 | 38,791,337 |
| Right of use | 4.9.17 | 12,575,819 | 14,622,686 | 4,850,297 | 5,694,264 |
| Investments in Property | 4.9.17 | 1,021,382 | 1,033,026 | 31,857 | 31,857 |
| Intangible assets | 4.9.17 | 59,683,415 | 60,381,322 | 30,758,887 | 31,436,048 |
| Company goodwill | 4.9.3 | 7,701,262 | 7,676,364 | 1,100,000 | 1,100,000 |
| Deferred tax assets | 1,217,512 | 287,378 | 0 | 0 | |
| Investments in subsidiaries, associates | 4.9.2 | 25,254,899 | 25,649,283 | 107,608,517 | 104,633,691 |
| Other long-term receivables | 339,237 | 408,207 | 222,628 | 231,228 | |
| Current assets | 244,927,997 | 251,973,162 | 117,054,362 | 119,516,988 | |
| Inventories | 4.9.4 | 107,998,681 | 108,595,399 | 46,670,984 | 49,258,450 |
| Trade receivables | 4.9.5 | 99,879,902 | 90,951,747 | 51,393,588 | 45,583,265 |
| Other receivables | 4.9.5 | 7,652,298 | 6,921,480 | 6,614,773 | 3,628,334 |
| Cash & cash equivalents | 4.9.6 | 23,186,916 | 40,595,341 | 6,164,817 | 16,137,744 |
| Financial assets at fair value through profit and loss | 4.9.7 | 6,210,201 | 4,909,195 | 6,210,201 | 4,909,195 |
| Total Assets | 440,020,029 | 435,374,438 | 302,488,596 | 301,435,412 | |
| Shareholders' EQUITY: | |||||
| Share capital | 4.9.13 | 54,504,437 | 54,504,438 | 54,504,438 | 54,504,438 |
| Share premium account | 40,676,356 | 40,676,356 | 40,676,356 | 40,676,356 | |
| Reserves | 17,783,176 | 17,463,998 | 126,450,525 | 141,131,347 | |
| Profit (losses) carried forward | 161,229,141 | 157,236,105 | (14,433,748) | (33,598,025) | |
| Amounts attributed for Capital Increase | |||||
| Total Shareholders' Equity | 274,193,110 | 269,880,896 | 207,197,569 | 202,714,115 | |
| Non controlling interest | 1,996,815 | 2,638,737 | 0 | 0 | |
| Total Equity | 276,189,925 | 272,519,633 | 207,197,569 | 202,714,115 | |
| LIABILITIES | |||||
| Long-term liabilities | 68,879,839 | 70,635,943 | 46,732,803 | 52,619,959 | |
| Loans | 4.9.10 | 48,413,329 | 48,607,624 | 38,496,250 | 44,000,000 |
| Lease liabilities | 8,601,116 | 10,595,268 | 3,190,104 | 3,974,856 | |
| Deferred tax liabilities | 5,989,671 | 5,642,981 | 2,205,342 | 1,812,104 | |
| Provisions for post employment employee benefits | 2,970,203 | 2,953,256 | 2,841,107 | 2,825,911 | |
| Provisions - Long-term liabilities | 4.9.9 | 2,905,520 | 2,836,813 | 0 | 7,087 |
| Short-term liabilities | 94,950,264 | 92,218,863 | 48,558,223 | 46,101,339 | |
| Suppliers | 4.9.8 | 52,779,295 | 64,800,497 | 24,280,172 | 29,662,690 |
| Other liabilities | 4.9.8 | 12,962,757 | 9,220,899 | 9,914,646 | 6,048,675 |
| Income taxes - other taxes payable | 8,438,481 | 5,745,599 | 4,120,584 | 2,499,440 | |
| Loans | 4.9.10 | 16,367,034 | 7,805,390 | 8,503,750 | 6,000,000 |
| Lease liabilities | 4,402,698 | 4,646,478 | 1,739,072 | 1,890,534 | |
| Total Equity & Liabilities | 440,020,029 | 435,374,438 | 302,488,596 | 301,435,412 |
| Group | Company | ||||
|---|---|---|---|---|---|
| Note | 01.01-30.06.2021 | 01.01-30.06.2020 | 01.01-30.06.2021 | 01.01-30.06.2020 | |
| Amounts in € | Total Activities | Total Activities | Total Activities | Total Activities | |
| Revenue | 4.9.1 | 195,235,968 | 183,688,988 | 82,512,885 | 81,334,988 |
| Cost of sales | (122,036,362) | (115,675,810) | (50,616,526) | (52,080,625) | |
| Gross operating profit | 73,199,605 | 68,013,177 | 31,896,360 | 29,254,363 | |
| Income from associates | 6,348,113 | 5,150,596 | 0 | 0 | |
| Other operating income | 292,448 | 699,176 | 796,768 | 845,292 | |
| Administrative expenses | (9,725,048) | (9,294,959) | (5,347,191) | (4,779,001) | |
| Distribution expenses | (45,213,870) | (42,310,438) | (22,500,501) | (21,534,697) | |
| Operating profit (loss) | 24,901,249 | 22,257,551 | 4,845,435 | 3,785,957 | |
| Financial Income-Expenses | 4.9.12 | (190,031) | (2,640,221) | 16,442,837 | 6,115,244 |
| Gain (loss) from revaluation of fixed assets | 0 | 12,360 | 0 | 0 | |
| Earnings (loss) before taxes | 24,711,218 | 19,629,690 | 21,288,272 | 9,901,200 | |
| Income tax | 4.9.11 | (5,551,973) | (5,165,571) | (807,370) | (947,812) |
| Deferred tax | 4.9.11 | 596,426 | 1,525,993 | (402,286) | 368,823 |
| Earnings (loss) after the deduction of tax (A) | 19,755,671 | 15,990,112 | 20,078,616 | 9,322,212 | |
| Owners of the parent | 19,506,183 | 15,617,534 | 20,078,616 | 9,322,212 | |
| Non controlling interest | 249,488 | 372,578 | 0 | 0 | |
| Other Comprehensive Income: | 0 | 0 | 0 | 0 | |
| Items not transferred to the statement of comprehensive income: |
9,049 | 7,453 | 9,049 | 7,453 | |
| Profit/Loss from actuarial study | 0 | 9,806 | 0 | 9,806 | |
| Actuarial study deferred tax | 0 | (2,354) | 0 | (2,354) | |
| Effect from change in tax rate | 9,049 | 0 | 9,049 | 0 | |
| Items which may be transferred in future to the statement of comprehensive income: |
2,484,609 | (4,603,458) | 0 | 0 | |
| Foreign exchange differences from subsidiaries abroad | 2,484,609 | (4,603,458) | 0 | 0 | |
| Other total income after taxes (Β) | 2,493,658 | (4,596,005) | 9,049 | 7,453 | |
| Total comprehensive income after taxes (A) + (B) | 22,249,329 | 11,394,107 | 20,087,665 | 9,329,665 | |
| Owners of the parent | 21,891,834 | 11,256,267 | 20,087,665 | 9,329,665 | |
| Non controlling interest | 357,495 | 137,840 | 0 | 0 | |
| Earnings (loss) per share, which correspond to the parent's shareholders for the period |
4.9.14 | 0.2912 | 0.2326 | 0.2997 | 0.1388 |
| Amounts in € | Share Capital | Share Premium | Readjustments Reserve and other reservesl |
Balance of profit / losses |
Total | Non controlling interest |
Total |
|---|---|---|---|---|---|---|---|
| Balance as at 1 January 2020 | 54,504,438 | 40,676,356 | 13,751,423 | 142,339,550 | 251,271,767 | 2,364,554 | 253,636,320 |
| Total comprehensive income for the period | |||||||
| Net profit for the period | 15,617,534 | 15,617,534 | 372,578 | 15,990,112 | |||
| Other comprehensive income | |||||||
| Foreign exchange differences | (4,368,720) | (4,368,720) | (234,738) | (4,603,458) | |||
| Reserve due to actuarial study | 7,453 | 7,453 | 7,453 | ||||
| Change from associates | |||||||
| Other comprehensive income | 7,453 | (4,368,720) | (4,361,268) | (234,738) | (4,596,006) | ||
| Other transactions registered in Equity | |||||||
| Total comprehensive income after taxes | 7,453 | 11,248,813 | 11,256,266 | 137,840 | 11,394,107 | ||
| Purchase of treasury shares | (81,929) | (81,929) | (81,929) | ||||
| Distributed dividends | (11,214,034) | (11,214,034) | (11,214,034) | ||||
| Formation of reserves | 3,989,277 | (3,989,277) | 0 | 0 | |||
| Change from associates | (90,577) | (90,577) | (90,577) | ||||
| Other transactions registered in Equity | 0 | 0 | 3,907,348 | (15,293,889) | (11,386,541) | (11,386,541) | |
| Balance as at 30 June 2020 | 54,504,438 | 40,676,356 | 17,666,224 | 138,294,476 | 251,141,493 | 2,502,394 | 253,643,887 |
| Balance as at 1 January 2021 | 54,504,437 | 40,676,356 | 17,463,998 | 157,236,104 | 269,880,895 | 2,638,737 | 272,519,632 |
| Total comprehensive income for the period | |||||||
| Net profit for the period | 19,506,183 | 19,506,183 | 249,488 | 19,755,671 | |||
| Other comprehensive income | |||||||
| Foreign exchange differences | 2,376,602 | 2,376,602 | 108,007 | 2,484,609 | |||
| Reserve due to actuarial study | 9,049 | 9,049 | 9,049 | ||||
| Other comprehensive income | 9,049 | 2,376,602 | 2,385,650 | 108,007 | 2,493,658 | ||
| Other transactions registered in Equity | |||||||
| Total comprehensive income after taxes | 9,049 | 21,882,785 | 21,891,834 | 357,495 | 22,249,329 | ||
| Purchase of treasury shares | (604,210) | (604,210) | (604,210) | ||||
| Distributed dividends | (15,000,000) | (15,000,000) | (15,000,000) | ||||
| Minority interests due to acquisition of interest in a subsidiary | (1,975,409) | (1,975,409) | (999,417) | (2,974,826) | |||
| Formation of reserves | 914,339 | (914,339) | 0 | 0 | |||
| Other transactions registered in Equity | 310,129 | (17,889,749) | (17,579,619) | (999,417) | (18,579,036) | ||
| Balance as at 30 June 2021 | 54,504,437 | 40,676,356 | 17,783,176 | 161,229,141 | 274,193,110 | 1,996,815 | 276,189,925 |
| Attributed to shareholders of the parent | ||||||
|---|---|---|---|---|---|---|
| Amounts in € | Share Capital | Share Premium | Readjustments Reserve and other reservesl |
Balance of profit / losses |
Total | |
| Balance as at 1 January 2020 | 54,504,438 | 40,676,356 | 137,114,752 | (35,743,113) | 196,552,433 | |
| Total comprehensive income for the period | ||||||
| Net profit for the period | 9,322,212 | 9,322,212 | ||||
| Other comprehensive income | ||||||
| Reserve due to actuarial study | 7,453 | 7,453 | ||||
| Other comprehensive income | 7,453 | 7,453 | ||||
| Other transactions registered in Equity | ||||||
| Total comprehensive income after taxes | 7,453 | 9,322,212 | 9,329,665 | |||
| Purchase of treasury shares | (81,929) | (81,929) | ||||
| Formation of reserves | 3,898,794 | (3,898,794) | 0 | |||
| Distributed dividends | (11,214,034) | (11,214,034) | ||||
| Other transactions registered in Equity | (7,397,170) | (3,898,794) | (11,295,964) | |||
| Balance as at 30 June 2020 | 54,504,438 | 40,676,356 | 129,725,035 | (30,319,695) | 194,586,134 | |
| Balance as at 1 January 2021 | 54,504,438 | 40,676,356 | 141,131,347 | (33,598,025) | 202,714,115 | |
| Total comprehensive income for the period | ||||||
| Net profit for the period | 20,078,616 | 20,078,616 | ||||
| Other comprehensive income | ||||||
| Reserve due to actuarial study | 9,049 | 9,049 | ||||
| Other comprehensive income | 9,049 | 9,049 | ||||
| Other transactions registered in Equity | ||||||
| Total comprehensive income after taxes | 9,049 | 20,078,616 | 20,087,665 | |||
| Purchase of treasury shares | (604,210) | (604,210) | ||||
| Distributed dividends | (15,000,000) | (15,000,000) | ||||
| Formation of reserves | 914,339 | (914,339) | 0 | |||
| Other transactions registered in Equity | (14,689,871) | (914,339) | (15,604,210) | |||
| Balance as at 30 June 2021 | 54,504,438 | 40,676,356 | 126,450,525 | (14,433,748) | 207,197,569 |
| Group | Company | ||||
|---|---|---|---|---|---|
| Amounts in € | 01.01 - 30.06.2021 01.01 - 30.06.2020 01.01 - 30.06.2021 01.01 - 30.06.2020 | ||||
| Operating Activities | |||||
| Earnings / (loss) before tax (continuing activities) | 24,711,218 | 19,629,690 | 21,288,272 | 9,901,200 | |
| Plus/minus adjustments for: | |||||
| Depreciation/Amortization | 6,418,410 | 6,180,538 | 3,405,400 | 3,320,268 | |
| Revaluation of fixed assets | 0 | (12,360) | 0 | 0 | |
| Foreign Exchange differences | 120,312 | 1,174,488 | (13,047) | (37,912) | |
| Results (income, expenses, profits and losses) from investing activities | (7,362,375) | (4,535,835) | (17,325,565) | (6,945,948) | |
| Interest expense and related expenses | 910,184 | 1,063,235 | 645,771 | 746,796 | |
| Decrease / (increase) in inventories | 1,574,030 | (15,587,470) | 2,587,466 | (4,774,445) | |
| Decrease / (increase) in receivables | (8,822,547) | (881,515) | (7,317,499) | (1,836,715) | |
| Decrease) / increase in liabilities (other than to banks) | (6,662,756) | 1,951,773 | (1,147,240) | 5,799,078 | |
| Less: | |||||
| Interest and related expenses paid | (729,727) | (1,011,334) | (584,375) | (756,594) | |
| Tax paid | (3,009,608) | (1,253,018) | 0 | 0 | |
| Total inflows / (outflows) from operating activities (a) | 7,147,141 | 6,718,194 | 1,539,185 | 5,415,730 | |
| Investing Activities | |||||
| Acquisition/Sale of subsidiaries, associates, joint ventures and other investments | (3,576,988) | (1,909,118) | (3,568,769) | (9,393,960) | |
| Purchase of tangible and intangible fixed assets | (16,756,147) | (17,626,841) | (3,920,440) | (13,603,372) | |
| Proceeds from sale of tangible and intangible assets | 126,806 | 96,569 | 58,002 | 5 6 |
|
| Interest received | 77,634 | 41,568 | 104,745 | 630,052 | |
| Dividends received | 5,253,323 | 2,940,005 | 14,967,688 | 12,258,250 | |
| Proceeds from grants | (201,241) | 787,366 | 0 | 0 | |
| Total inflows / (outflows) from investing activities (b) | (15,076,613) | (15,670,451) | 7,641,227 | (10,108,973) | |
| Financing Activities | |||||
| Proceeds from loans granted / assumed | 23,184,426 | 31,234,192 | 12,000,000 | 30,000,000 | |
| Payment of borrowings | (15,000,000) | (28,971,356) | (15,000,000) | (25,000,000) | |
| Payment of lease liabilities | (2,312,329) | (1,968,545) | (886,137) | (847,587) | |
| (Payments) / Proceeds from (purchase) / sale of treasury shares | (604,210) | (81,929) | (604,210) | (81,929) | |
| Dividends paid towards the shareholders of the parent | (14,662,991) | (10,946,094) | (14,662,991) | (10,946,094) | |
| Total inflows / (outflows) from financing activities (c) | (9,395,104) | (10,733,733) | (19,153,338) | (6,875,611) | |
| Net increase / (decrease) in cash and cash equivalents (a+b+c) | (17,324,576) | (19,685,990) | (9,972,927) | (11,568,854) | |
| Cash and cash equivalents at beginning of period | 40,595,341 | 54,847,405 | 16,137,744 | 30,278,899 | |
| Effect from foreign exchange differences due to translation to euro | (83,850) | (677,084) | 0 | 0 | |
| Cash and cash equivalents at the end of the period | 23,186,916 | 34,484,332 | 6,164,817 | 18,710,045 |
Gr. Sarantis SA (the Company) has the legal form of a société anonyme and is the parent company of the Gr. Sarantis SA group (the group).
The Company's headquarters is located at 26 Amarousiou – Chalandriou Street, Marousi Greece, The Company's central offices are also located at the same address.
The shares of Gr. Sarantis SA are listed on the main market of the Athens Exchange.
The Group's companies, which are included in the consolidated financial statements, are the following:
| GROUP STRUCTURE | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Company | Domicile | Direct Participation Percentage |
Indirect Participation Percentage |
Total | |||||
| GR. SARANTIS S.A. | GREECE | PARENT | |||||||
| SARANTIS BULGARIA LTD | BULGARIA | 100.00% | 0.00% | 100.00% | |||||
| SARANTIS ROMANIA S.A. | ROMANIA | 100.00% | 0.00% | 100.00% | |||||
| SARANTIS BELGRADE D.O.O. | SERBIA | 100.00% | 0.00% | 100.00% | |||||
| SARANTIS BANJA LUKA D.O.O. | BOSNIA | 0.00% | 100.00% | 100.00% | |||||
| SARANTIS SKOPJE D.O.O. | F.Y.R.O.M. | 0.00% | 100.00% | 100.00% | |||||
| SARANTIS POLSKA S.A. | POLAND | 100.00% | 0.00% | 100.00% | |||||
| POLIPAK SP. Z.O.O. | POLAND | 0.00% | 80.00% | 80.00% | |||||
| SARANTIS CZECH REPUBLIC sro | CZECH REPUBLIC | 100.00% | 0.00% | 100.00% | |||||
| SARANTIS HUNGARY Kft. | HUNGARY | 100.00% | 0.00% | 100.00% | |||||
| ZETAFIN LTD | CYPRUS | 100.00% | 0.00% | 100.00% | |||||
| ZETA COSMETICS LTD | CYPRUS | 0.00% | 100.00% | 100.00% | |||||
| WALDECK LTD | CYPRUS | 0.00% | 100.00% | 100.00% | |||||
| ELODE FRANCE S.A.R.L | FRANCE | 100.00% | 0.00% | 100.00% | |||||
| SARANTIS FRANCE S.A.R.L | FRANCE | 100.00% | 0.00% | 100.00% | |||||
| SARANTIS PORTUGAL Lda | PORTUGAL | 100.00% | 0.00% | 100.00% | |||||
| ASTRID T.M. A.S. | CZECH REPUBLIC | 100.00% | 0.00% | 100.00% | |||||
| SARANTIS SLOVAKIA S.R.O | SLOVAKIA | 0.00% | 100.00% | 100.00% | |||||
| IVYBRIDGE VENTURES LTD | CYPRUS | 100.00% | 0.00% | 100.00% | |||||
| SARANTIS UKRAINE LLC | UKRAINE | 100.00% | 0.00% | 100.00% | |||||
| ERGOPACK LLC | UKRAINE | 0.00% | 100.00% | 100.00% | |||||
| HOZTORG LLC | RUSSIA | 0.00% | 100.00% | 100.00% | |||||
| Equity Consolidation Method | |||||||||
| ELCA COSMETICS LTD | CYPRUS | 0.00% | 49.00% | 49.00% | |||||
| ESTEE LAUDER HELLAS S.A. | GREECE | 0.00% | 49.00% | 49.00% | |||||
| ΕSTEE LAUDER BULGARIA EOOD | BULGARIA | 0.00% | 49.00% | 49.00% | |||||
| ESTEE LAUDER ROMANIA S.A. | ROMANIA | 0.00% | 49.00% | 49.00% s |
On 26/05/2021, 10% of IVYBRIDGE was acquired by the Company, and therefore the Group now owns 100% of both the direct participation of IVYBRIDGE, as well as the indirect participation of the subsidiaries ERGOPACK and HOZTORG.
The Group is active in the production and trade of cosmetics, household products and parapharmaceutical items.
The Group's basic activities have not changed since the previous year.
The consolidated and separate financial statements of "GR. SARANTIS S.A." are in accordance with the International Financial Reporting Standards (IFRS), which have been issued by the International Accounting Standards Board (IASB) as well as their interpretations which have been issued by the International Financial Reporting Interpretations Committee (IFRIC) of IASB and have been adopted by the European Union.
The interim consolidated financial statements for the period ended on 30th June 2020, have been prepared in accordance with IAS 34 "Interim Financial Reporting". The financial statements do not include all disclosures that would otherwise be required in a complete set of annual financial statements and should be read in conjunction with the financial statements of the Company and the Group as of 31st December 2020. The latter are available at the Company's website www.sarantisgroup.com .
The interim consolidated financial statements have been approved by the Company's Board of Directors on September 8 th 2021.
The present interim consolidated financial statements include the financial statements of "GR. SARANTIS S.A." and its subsidiaries, which together are referred to as the group, and cover the period from January 1st 2021 to June 30th 2021.
The present financial statements are presented in €, which is the group's operating currency, namely the currency of the primary economic environment in which the parent company operates.
The preparation of the Financial Statements according to the International Accounting Standards requires the implementation of estimations, judgments and assumptions that may affect the accounting balances of assets and liabilities and the required disclosures for contingent receivables and liabilities, as well as the amount of income and expenses recognized.
During the preparation of the current interim condensed financial statements, the significant accounting judgments and estimations that were adopted by the Management in the application of the Group's accounting policies, as well as the major sources for estimation of the uncertainty, remained unchanged as compared to the ones applied in the annual financial statements of 31st December 2020, except for those that concern the adoption of the new IFRS that were set in effect on 1st January 2021 (see note 4.7.7).
Sarantis Group, with an utmost sense of responsibility, closely monitors the recent developments and responds appropriately at all levels, having prepared a specific coronavirus action plan, according to the evolution of the pandemic across its geographical region.
The Group responded with great flexibility and sensitivity, supported by its people, although the continuous challenges throughout the countries of its activity.
Since the beginning of the COVID-19 outbreak, set out its key priorities:
• Ensuring the protection and safety of employees, customers, partners, consumers, as well as the ongoing support of social groups in need, especially those at the forefront of the pandemic and caring for those affected.
Since the beginning of the pandemic, when the virus started to spread worldwide, the Group enacted a special management team and precautionary measures in line with each state's government in which it operates and in accordance with the official WHO's guidelines.
In Greece, a special coronavirus protection policy was enacted which includes remote working, suspension of both professional and personal travel, cancellation of both internal and external events, the headquarters' decontamination and special health guidance. In the other countries of its operation, the Group aligned with the precautionary measures taken by the authorities and implemented remote work and further specific protection measures.
Since then, the Group maintains safety and hygiene measures across its facilities and adapts according to the restrictive measures imposed by governments and relevant authorities in the countries of its operation, as the pandemic is still evolving.
In addition, the Group's contribution to the society was intensified during the pandemic, focusing on strengthening the health sector and supporting those in need in the Group's countries, through product and monetary donations, as well as donations in-kind to hospitals, nursing homes, NGOs and other socially vulnerable groups.
Moreover, during the quarantine period, we offered internally information on the pandemic and health & wellbeing promotion services [eg. healthy nutrition habits within the quarantine, alternative proposals of leisure entertainment like seminars, online theaters, online books, online tours, etc].
• Implementing contingency and business continuity plans in order to safeguard production plants and enable the Group's supply chain to remain fully operational in order to ensure the uninterrupted business continuity and the continuous supply of high-demand products to the market.
As the needs of the consumers turned to specific product categories, the Group ensured its ability to respond to increased demand for specific product categories, such as home care and personal hygiene products as well as food supplements.
In addition, the Group entered into the production of antibacterial products, in the hand cleansing category, in order to meet the high demand for these products.
Amidst this extraordinary environment, and as the Group's priorities remained focused on the health & safety of its employees and the society and its uninterrupted business continuity, the Group managed to maintain a solid financial position and free cashflow generation, while executing its investment plan and creating further value to all stakeholders.
During the first half of 2021, investments realized relate to new product development, upgrading machinery equipment, expanding production capacity, while a dividend payment was done to the shareholders of the Company.
Given the continued uncertainty regarding the impact of the COVID-19, including macroeconomic and consumption impacts, as well as the uncertain evolution of the pandemic going forward across our geographical
region, financial results cannot be accurately predicted at the time.
However, the management is confident that the Group's agility and resilient business model, together with our people's capabilities, will help us navigate through this unprecedented period and allow us to continue following the Group's strategic expansion plan, stimulating further profitable growth. The Group's strong capital base, low net debt and strong cash flows, provide safety and the support necessary to mitigate any potential negative impact, enabling it to continue as a going concern.
The significant accounting principles that were applied for the preparation of the interim condensed financial statements of the Group are in agreement with those that were adopted during the preparation of the annual financial statements of the Group for the year ended on 31st December 2019 except for the new standards and interpretations that were adopted whose application is mandatory for periods after 1st January 2021.
Furthermore, the financial statements include selected notes for the explanation of events and transactions, which are significant for the understanding of changes in the Group's and Company's financial position as compared to the latest available and published annual financial statements.
| IFRS | IASB Effective Date |
|---|---|
| IBOR reform and its effects on financial report – phase 2 | 1 January 2021 |
New and amended standards and Interpretations issued by the IASB that will apply for the first time in the next annual financial statements are not expected to impact the Group as they are either not relevant to the Group's activities or require accounting which is consistent with the Group's current accounting policies.
In addition to the above pronouncements, the IFRS Interpretations Committee has issued a number of agenda decisions which set out the Interpretations Committee's rationale on how the requirements of applicable IFRSs should be applied. Since 30 June 2020, agenda decisions have been finalised on the following topics:
| Accounting Standard | Topic |
|---|---|
| IAS 1 Presentation of Financial Statements | Supply Chain Financing Arrangements – Reverse Factoring |
| IAS 38 Intangible Assets | Configuration or Customisation Costs in a Cloud Computing Arrangement |
| IFRS 9 Financial Instruments | Hedging Variability in Cash Flows due to Real Interest Rates |
| IAS 19 Employee Benefits | Attributing Benefit to Periods of Service |
| IAS 10 Events after the Reporting Period | Preparation of Financial Statements when an Entity is No Longer a Going Concern |
| IAS 2 Inventories | Costs Necessary to Sell Inventories |
The IFRS Interpretations Committee (IFRS IC) has issued, in May 2021, a tentative decision "Attributing Benefit to Periods of Service (IAS 19 Employee Benefits)" where additional explanatory application guidance is provided on the method used to attribute employee benefits on specific defined benefit schemes with similar characteristics of the scheme contemplated in article 8 of legislation Ν.3198/1955 which refers to staff retirement indemnity.
The application guidance modifies the method currently used in Greece to apply the basic principles of IAS 19 and as a result, entities which prepare IFRS financial statements are required to change their accounting policy accordingly. The tentative decision is effective immediately however, it was impracticable to be applied in the interim financial statements as at 30th June 2021.
Any changes will be presented as a change in accounting policy and applied retrospectively in the annual financial statements for the year ending 31 December 2021, adjusting comparatives balances for 2020 and the opening balance of reserves for amounts relating to previous periods, as if the new policy had always been applied.
The Company is currently investigating the impact of the change in the method to attribute the retirement benefits.
| Mandatorily effective for periods beginning on or after |
|
|---|---|
| IFRS 16 Leases: Covid-19-Related Rent Concessions beyond 30 June 2021 | 1 April 2021 |
| Annual Improvements to IFRSs - 2018-2020 cycle | 1 January 2022 |
| IAS 16 Property, Plant and Equipment (Amendment – Proceeds before Intended Use) |
1 January 2022 |
| IAS 37 Provisions, Contingent Liabilities and Contingent Assets (Amendment – Onerous Contracts – Cost of Fulfilling a Contract) |
1 January 2022 |
| IFRS 3 Business Combinations (Amendment – Reference to the Conceptual Framework) |
1 January 2022 |
| IFRS 17 Insurance Contracts | 1 January 2023 |
| IAS 1 Presentation of Financial Statements and IAS 8 Accounting Policies, Changes in Accounting Estimates and Errors (Amendment – Classification of Liabilities as Current or Non-current) |
1 January 2023 |
| IAS 1 Presentation of Financial Statements and IFRS Practice Statement 2 (Amendment – Disclosure of Accounting Policies) |
1 January 2023 |
| IAS 8 Accounting policies, Changes in Accounting Estimates and Errors (Amendment - Definition of Accounting Estimates) |
1 January 2023 |
| IAS 12 Income Taxes (Amendment - Deferred Tax related to Assets and Liabilities arising from a Single Transaction) |
1 January 2023 |
The Company and the Group are currently investigating the impact of the new standards and amendments on its financial statements.
The Group's objectives as regards to management of capital, is to reassure the ability for the Group's smooth operation, aiming at providing satisfactory returns to shareholders and to maintain an ideal capital structure by reducing thus the cost of capital. The Group monitors its capital based on the leverage ratio. The leverage ratio is calculated by dividing net debt with total employed capital. Net debt is calculated as "Total debt" (including "short term and long-term debt" as presented in the Statement of Financial Position) minus "Cash and cash equivalents" and "financial assets at fair value through the profit and loss". The calculation of net debt does not include the
purchase of treasury shares. Total employed capital is calculated as "Shareholders' Equity" as presented in the statement of financial position plus net debt. The leverage ratio on 30 June 2021 was as follows:
| Group | |||
|---|---|---|---|
| Amounts in € | 30.06.2021 | 31.12.2020 | |
| Total Debt | 64,780,363 | 56,413,014 | |
| Minus | |||
| Cash & cash equivalents | (23,186,916) | (40,595,341) | |
| Financial assets at fair value through profit and loss | (6,210,201) | (4,909,195) | |
| Net Debt | 35,383,246 | 10,908,477 | |
| Shareholders' Equity | 274,193,110 | 269,880,896 | |
| Total Employed Capital | 309,576,356 | 280,789,373 | |
| Leverage Ratio | 11.43% | 3.88% |
The Group's financial instruments mainly consist of bank deposits, bank overdrafts, trade debtors and creditors, investments in securities, other liabilities.
The financial assets and liabilities during the date of the financial statements can be classified as follows:
| Group | Company | |||
|---|---|---|---|---|
| Amounts in € | 30.06.2021 | 31.12.2020 | 30.06.2021 | 31.12.2020 |
| Non-current assets | ||||
| Other long-term receivables | 339,237 | 408,207 | 222,628 | 231,228 |
| Total | 339,237 | 408,207 | 222,628 | 231,228 |
| Current assets | ||||
| Trade receivables | 99,879,902 | 90,951,747 | 51,393,588 | 45,583,265 |
| Other receivables | 7,652,298 | 6,921,480 | 6,614,773 | 3,628,334 |
| Cash & cash equivalents | 23,186,916 | 40,595,341 | 6,164,817 | 16,137,744 |
| Financial assets at fair value through profit and loss | 6,210,201 | 4,909,195 | 6,210,201 | 4,909,195 |
| Total | 136,929,316 | 143,377,763 | 70,383,379 | 70,258,538 |
| Long-term Liabilities | ||||
| Loans | 48,413,329 | 48,607,624 | 38,496,250 | 44,000,000 |
| Lease liabilities | 8,601,116 | 10,595,268 | 3,190,104 | 3,974,856 |
| Provisions and other long-term liabilities | 2,905,520 | 2,836,813 | 0 | 7,087 |
| Total | 59,919,965 | 62,039,705 | 41,686,354 | 47,981,943 |
| Short-term Liabilities | ||||
| Loans | 16,367,034 | 7,805,390 | 8,503,750 | 6,000,000 |
| Lease liabilities | 4,402,698 | 4,646,478 | 1,739,072 | 1,890,534 |
| Suppliers | 52,779,295 | 64,800,497 | 24,280,172 | 29,662,690 |
| Other liabilities | 12,962,757 | 9,220,899 | 9,914,646 | 6,048,675 |
| Total | 86,511,783 | 86,473,264 | 44,437,640 | 43,601,899 |
The following table presents the fixed assets measured at fair value, according to the measurement method. The different categories are as follows:
• Published market prices (without amendment or adjustment) for the financial assets traded in active money markets (level 1)
• Measurement or valuation techniques based directly on publicized market prices or calculated indirectly from publicized market prices for similar instruments (level 2).
• Measurement or valuation techniques that are not based on available information from current transactions in active money markets (level 3).
The financial assets measured at fair value during 30 June 2021 are as follows:
| Group | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Assets | Level 1 | Level 2 | Level 3 | Total | |||||
| Tangible fixed assets | 0 | 61,699,941 | 0 | 61,699,941 | |||||
| Investments in Property | 0 | 1,021,382 | 0 | 1,021,382 | |||||
| Financial Assets at Fair Value through Profit and Loss | 6,210,201 | 0 | 0 | 6,210,201 |
| Company | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Assets | Level 1 | Level 2 | Level 3 | Total | |||||
| Tangible fixed assets | 0 | 27,904,147 | 0 | 27,904,147 | |||||
| Investments in Property | 0 | 31,857 | 0 | 31,857 | |||||
| Financial Assets at Fair Value through Profit and Loss | 6,210,201 | 0 | 0 | 6,210,201 |
The fair value of own-use tangible fixed assets and investments in property is carried out by approved appraiser based on international rules and standards.
The fair value of financial assets traded on active markets (i.e. derivatives, equity, bonds, mutual funds), is defined based on the published prices in effect during the balance sheet date. A market is considered "Active" when there are available and revised prices in frequent intervals that are published by a stock exchange, broker, sector, rating agency or regulatory authority. Such financial instruments are included in level 1.
The fair value of financial assets not traded on active markets (i.e. over the counter derivative contracts) is defined using valuation techniques that are based primarily on available information for transactions carried out in active markets, while they use the least possible estimations by the entity. Such financial instruments are included in level 2.
If the valuation techniques are not based on available market information, then the financial instruments are included in level 3.
For management purposes, the Group is organized in four basic business segments: Mass Market Cosmetics, Household Products, Other Sales and the Private Label Products. According to IFRS 8 – Operating Segments, the management monitors the operating results of the business segments separately with the objective to evaluate the performance and decision making as regards to the allocation of resources. The Group's results per segment are analyzed as follows:
| Commercial Activity Sectors | Personal Care | Home Care | Other Sales | Private Label (Polipak) |
Income from associate companies |
Group Total |
|---|---|---|---|---|---|---|
| Income from external customers | 85,089,189 | 76,129,433 | 22,565,949 | 11,451,397 | 0 | 195,235,968 |
| Earnings before interest & tax (EBIT) | 5,850,397 | 9,563,632 | 2,036,916 | 1,102,191 | 6,348,113 | 24,901,249 |
| Interest income | 21,532 | 19,265 | 5,710 | 2,898 | 0 | 49,405 |
| Interest expenses | (260,275) | (232,869) | (69,026) | (35,028) | 0 | (597,198) |
| Earnings before tax | 5,767,577 | 9,489,532 | 2,014,951 | 1,091,045 | 6,348,113 | 24,711,218 |
| Income tax | 1,097,654 | 1,805,997 | 383,475 | 207,642 | 1,460,779 | 4,955,546 |
| Earnings / losses after tax | 4,669,922 | 7,683,535 | 1,631,477 | 883,403 | 4,887,334 | 19,755,671 |
| Depreciation / amortization | 2,718,211 | 2,431,987 | 720,879 | 547,333 | 0 | 6,418,410 |
| Earnings before interest, tax, depreciation & amortization (EBITDA) |
8,568,608 | 11,995,619 | 2,757,795 | 1,649,524 | 6,348,113 | 31,319,659 |
| Commercial Activity Sectors | Personal Care | Home Care | Other Sales | Private Label (Polipak) |
Income from associate companies |
Group Total |
|---|---|---|---|---|---|---|
| Income from external customers | 78,769,632 | 71,669,648 | 22,377,990 | 10,871,718 | 0 | 183,688,988 |
| Earnings before interest & tax (EBIT) | 5,046,986 | 8,524,028 | 1,996,448 | 1,539,494 | 5,150,596 | 22,257,551 |
| Interest income | 14,891 | 13,549 | 4,230 | 2,055 | 0 | 34,726 |
| Interest expenses | (318,204) | (289,522) | (90,400) | (43,918) | 0 | (742,045) |
| Earnings before tax | 3,920,104 | 7,498,719 | 1,676,308 | 1,383,963 | 5,150,596 | 19,629,690 |
| Income tax | 694,533 | 1,328,563 | 296,995 | 245,199 | 1,074,288 | 3,639,578 |
| Earnings / losses after tax | 3,225,572 | 6,170,156 | 1,379,313 | 1,138,763 | 4,076,308 | 15,990,112 |
| Depreciation / amortization | 2,571,591 | 2,339,798 | 730,574 | 538,575 | 0 | 6,180,538 |
| Earnings before interest, tax, depreciation & amortization (EBITDA) |
7,618,577 | 10,863,826 | 2,727,022 | 2,078,069 | 5,150,596 | 28,438,089 |
Income from associate companies refers to income from the company Elsa Cosmetics Ltd and its subsidiaries.
The calculation of financial income & expenses and depreciation, amortization has been proportionate based on the sales of each business activity of the Group. The calculation of income tax is based proportionately on the earnings before tax of each of the Group's business activity.
The allocation of consolidated assets and liabilities to the Group's business segments is analyzed as follows:
| Group | Personal Care | Home Care | Other Sales | Private Label (Polipak) | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 30.06.2021 | 31.12.2020 | 30.06.2021 | 31.12.2020 | 30.06.2021 | 31.12.2020 | 30.06.2021 | 31.12.2020 | 30.06.2021 | 31.12.2020 | |
| Total Assets | 440,020,029 | 435,374,438 | 182,143,142 | 183,817,549 | 162,963,758 | 172,887,821 | 48,304,994 | 53,707,509 | 46,608,134 | 24,961,559 |
| Total Liabilities | 163,830,104 | 162,854,806 | 64,457,266 | 66,080,707 | 57,670,018 | 62,151,571 | 17,094,291 | 19,307,352 | 24,608,529 | 15,315,176 |
Οι πωλήσεις του Ομίλου και τα μη κυκλοφοριακά στοιχεία ενεργητικού κατανέμονται ανά γεωγραφική περιοχή ως κάτωθι:
| Revenue | 01.01 - 30.06.2021 |
01.01 - 30.06.2020 |
Non Current Assets | 30.06.2021 | 31.12.2020 |
|---|---|---|---|---|---|
| Greece | 69,245,900 | 67,635,771 | Greece | 77,825,717 | 77,284,733 |
| Poland | 46,809,068 | 42,452,175 | Poland | 46,505,869 | 34,391,475 |
| Romania | 27,555,817 | 24,215,643 | Romania | 7,754,974 | 8,132,130 |
| Bulgaria | 6,134,638 | 5,161,374 | Bulgaria | 919,639 | 1,086,424 |
| Serbia | 9,117,371 | 8,888,924 | Serbia | 890,989 | 1,048,399 |
| Czech | 11,027,632 | 9,558,093 | Czech | 15,941,330 | 15,838,665 |
| Slovakia | 2,951,179 | 2,936,760 | Slovakia | 326,324 | 339,012 |
| Hungary | 4,497,737 | 4,497,650 | Hungary | 2,050,421 | 2,137,242 |
| North Macedonia | 2,032,605 | 1,927,583 | North Macedonia | 447,057 | 514,753 |
| Bosnia | 1,568,128 | 1,318,080 | Bosnia | 221,374 | 256,061 |
| Portugal | 725,246 | 616,932 | Portugal | 2,111 | 4,355 |
| Ukraine | 12,603,024 | 13,342,220 | Ukraine | 16,857,290 | 16,627,371 |
| Russia | 967,623 | 1,137,781 | Russia | 93,440 | 90,787 |
| Cyprus | 0 | 0 | Cyprus | 25,254,899 | 25,649,283 |
| France | 0 | 0 | France | 597 | 585 |
| Total | 195,235,968 | 183,688,988 | Total | 195,092,031 | 183,401,276 |
The consolidated financial statements of Sarantis Group incorporate the consolidated financial results of the company ELCA Cosmetics Ltd, based on the equity method.
The movement of the Group's participations in associate companies and joint ventures is analyzed as follows:
| Amounts in € | ||
|---|---|---|
| Group | 30.06.2021 | 31.12.2020 |
| Opening Balance | 25,649,283 | 21,458,228 |
| Participation on associates gains | 4,887,334 | 9,222,158 |
| Dividends | (5,253,323) | (4,914,211) |
| Other total income | (79,915) | |
| Foreign exchange differences | (28,395) | (36,976) |
| Ending Balance | 25,254,899 | 25,649,283 |
It is noted that the group and the company The Estée Lauder Companies Inc. ("EL") have agreed to amend the Shareholders Agreement governing ELCA, which was going to end in 2021, extending the term of the arrangement from June 30, 2021 to June 30, 2028.
Based on the new agreement, EL will have the right to increase its interest in ELCA to 100% by purchasing shares held by the Group, until June 30, 2027.
The goodwill of the Group and the Company are analyzed as follows:
| Amounts in Euros | Group | Company |
|---|---|---|
| Balance as at 1.1.2021 | 7,676,364 | 1,100,000 |
| Acquisitions / Reductions | ||
| Impairments/Revaluation | ||
| Foreign exchange differences | 24,897 | |
| Balance as at 30.06.2021 | 7,701,262 | 1,100,000 |
| Amounts in Euros | Group | Company |
|---|---|---|
| Balance as at 1.1.2020 | 7,898,422 | 1,100,000 |
| Acquisitions / Reductions | ||
| Impairments/Revaluation | ||
| Foreign exchange differences | (222,058) | |
| Balance as at 31.12.2020 | 7,676,364 | 1,100,000 |
The inventories are analyzed as follows:
| Group | 30.06.2021 | 31.12.2020 |
|---|---|---|
| Merchandise | 78,859,044 | 79,753,887 |
| Products | 10,831,830 | 12,353,966 |
| Raw Materials | 15,874,134 | 17,839,677 |
| Prepayments for stock purchase | 3,110,561 | 860,997 |
| Impairment due to obsolescence | (676,888) | (2,213,126) |
| Total | 107,998,681 | 108,595,399 |
| Company | 30.06.2021 | 31.12.2020 |
|---|---|---|
| Merchandise | 27,326,616 | 26,961,135 |
| Products | 9,657,854 | 11,344,251 |
| Raw Materials | 8,834,646 | 12,157,803 |
| Prepayments for stock purchase | 1,043,029 | 437,133 |
| Impairment due to obsolescence | (191,162) | (1,641,873) |
| Total | 46,670,984 | 49,258,450 |
There is no pledge over the Group's and the Company's inventories.
The analysis of the provision for the impairment due to obsolescence is as follows:
| Group | 30.06.2021 | 31.12.2020 |
|---|---|---|
| Opening Balance | 2,213,126 | 2,274,919 |
| Provision | 1,268,182 | 1,800,893 |
| Use of provision | (2,818,596) | (1,751,445) |
| Provision reserve | (999) | (38,886) |
| Foreign exchange differences | 15,174 | (72,354) |
| Closing balance | 676,887 | 2,213,126 |
| Company | 30.06.2021 | 31.12.2020 |
| Opening Balance | 1,641,873 | 1,492,317 |
| Provision | 1,012,982 | 1,446,621 |
| Use of provision | (2,463,694) | (1,297,064) |
| Provision reserve | ||
| Foreign exchange differences |
No inventories were impaired due to reduced sales or operational suspension. It is noted that more than 90% of the Group's sales are generated from categories such as personal care & hygiene, home care and health & care, categories which are in high demand due to the needs arising from COVID-19.
The trade receivables account is analyzed as follows:
| Group | 30.06.2021 | 31.12.2020 |
|---|---|---|
| Trade receivables | 79,106,643 | 83,238,504 |
| Minus provisions | (3,315,275) | (3,550,375) |
| Net trade receivables | 75,791,368 | 79,688,129 |
| Checks and notes receivable | 26,488,534 | 13,663,618 |
| Minus provisions | (2,400,000) | (2,400,000) |
| Net checks and notes receivable | 24,088,534 | 11,263,618 |
| Total | 99,879,902 | 90,951,747 |
| Company | 30.06.2021 | 31.12.2020 |
|---|---|---|
| Trade receivables | 30,004,657 | 36,932,468 |
| Minus provisions | (1,877,090) | (1,855,636) |
| Net trade receivables | 28,127,567 | 35,076,832 |
| Checks and notes receivable | 25,666,021 | 12,906,433 |
| Minus provisions | (2,400,000) | (2,400,000) |
| Net checks and notes receivable | 23,266,021 | 10,506,433 |
| Total | 51,393,588 | 45,583,265 |
As the Group's core sales network focuses on the mass market retail channel, which has remained fully operational due to increased consumer needs, there is a normal flow of receivables from customers.
The other receivables are analyzed as follows:
| Group | 30.06.2021 | 31.12.2020 |
|---|---|---|
| Accounts receivable in legal contest | 425,132 | 425,134 |
| Sundry Debtors | 5,018,425 | 3,146,064 |
| Short-term Lease Receivables | 91,503 | 216,755 |
| Prepayments and accrued income | 2,480,117 | 3,397,279 |
| Accounts for management of prepayments & credits | 47,382 | 46,511 |
| Minus provisions | (410,261) | (310,264) |
| Total | 7,652,298 | 6,921,480 |
| Company | 30.06.2021 | 31.12.2020 |
| Accounts receivable in legal contest | 425,136 | 425,136 |
| Sundry Debtors | 1,611,953 | 713,750 |
| Receivables from dividends | 3,067,848 | 1,728,348 |
| Short-term Lease Receivables | 91,503 | 181,871 |
| Prepayments and accrued income | 1,781,215 | 842,983 |
| Accounts for management of prepayments & credits | 47,382 | 46,511 |
| Minus provisions | (410,266) | (310,266) |
| Total | 6,614,773 | 3,628,334 |
The analysis of the provision for trade receivables and for other receivables is as follows:
| Group | 30.06.2021 | 31.12.2020 |
|---|---|---|
| Opening balance | 6,260,639 | 6,446,024 |
| Additions | 119,484 | 207,822 |
| Receivables written off | -334,120 | -19,434 |
| Amounts offset | 10,011 | -83,461 |
| Foreign exchange differences | 69,523 | -290,311 |
| Υπόλοιπο λήξης | 6,125,537 | 6,260,639 |
| Company | 30.06.2021 | 31.12.2020 |
| Opening balance | 4,565,901 | 4,506,280 |
| Additions | 100,000 | 67,045 |
| Receivables written off | 0 | 0 |
| Amounts offset | 21,454 | -7,423 |
| Υπόλοιπο λήξης | 4,687,355 | 4,565,901 |
Cash & cash equivalents represent cash in hand of the Group and company and bank deposits available at first demand, which are analyzed as follows:
| Group | 30.06.2021 | 31.12.2020 |
|---|---|---|
| Cash in hand | 126,623 | 342,844 |
| Bank deposits | 23,060,293 | 40,252,497 |
| Total | 23,186,916 | 40,595,341 |
| Company | 30.06.2021 | 31.12.2020 |
| Cash in hand | 102,508 | 322,674 |
| Bank deposits | 6,062,309 | 15,815,070 |
| Group | Company | ||||
|---|---|---|---|---|---|
| 30.06.2021 31.12.2020 |
30.06.2021 | 31.12.2020 | |||
| Opening Balance | 4,909,195 | 2,514,360 | 4,909,195 | 2,514,360 | |
| Acquisitions | 3,952,342 | 9,041,818 | 3,952,342 | 9,041,818 | |
| Cost of disposals | (3,069,816) | (6,457,126) | (3,069,816) | (6,457,126) | |
| Fair value adjustments | 418,479 | (189,857) | 418,479 | (189,857) | |
| Foreign exchange differences | |||||
| Closing balance | 6,210,201 | 4,909,195 | 6,210,201 | 4,909,195 |
The above items are placements with a short-term investment horizon that are traded on active markets.
The Company's and Group's trade and other liabilities are analyzed as follows:
| Group | 30.06.2021 | 31.12.2020 |
|---|---|---|
| Suppliers | 50,267,167 | 60,921,970 |
| Checks payable | 2,512,128 | 3,878,527 |
| Total | 52,779,295 | 64,800,497 |
| Company | 30.06.2021 | 31.12.2020 |
| Suppliers | 21,768,044 | 25,784,163 |
| Checks payable | 2,512,128 | 3,878,527 |
The other liabilities of the Company and the Group are analyzed as follows:
| Group | 30.06.2021 | 31.12.2020 |
|---|---|---|
| Social Security Funds | 1,279,336 | 1,780,949 |
| Customer Prepayments | 1,002,683 | 1,668,507 |
| Long-term Liabilities payable in the following year | 0 | 24,464 |
| Government Grants | 1,095,715 | 1,215,936 |
| Dividends Payable | 32,224 | 33,104 |
| Accruals and deferred expenses | 5,930,907 | 3,131,359 |
| Sundry Creditors | 3,621,891 | 1,366,579 |
| Total | 12,962,757 | 9,220,899 |
| Company | 30.06.2021 | 31.12.2020 |
| Social Security Funds | 645,886 | 1,167,084 |
| Customer Prepayments | 3,860,143 | 2,487,567 |
| Short-term Liabilities towards Related Companies | 548,255 | 558,255 |
| Government Grants | 14,697 | 8,885 |
| Dividends Payable | 32,224 | 33,104 |
| Accruals and deferred expenses | 1,905,153 | 967,491 |
| Sundry Creditors | 2,908,287 | 826,290 |
The Group does not depend on suppliers who have suspended their operations or who are expected to be significantly affected by COVID-19.
The provisions and other long-term liabilities are analyzed as follows:
| Group | 30.06.2021 | 31.12.2020 |
|---|---|---|
| Government Grants | 2,215,314 | 2,177,277 |
| Other provisions | 548,972 | 492,429 |
| Other long-term liabilities | 141,234 | 167,107 |
| Total | 2,905,520 | 2,836,813 |
| Company | 30.06.2021 | 31.12.2020 |
| Government Grants | 0 | 7,087 |
| Total | 0 | 7,087 |
Loans are analyzed as follows:
| Group | Company | |||||
|---|---|---|---|---|---|---|
| Short-term loans | 30.06.2021 | 31.12.2020 | 30.06.2021 | 31.12.2020 | ||
| Bank loans | 15,323,284 | 7,805,390 | 1,460,000 | 0 | ||
| Bond Loans | 1,043,750 | 0 | 7,043,750 | 6,000,000 | ||
| Long-term loans | ||||||
| Bank loans | 39,457,079 | 28,607,624 | 8,540,000 | 0 | ||
| Bond Loans | 8,956,250 | 20,000,000 | 29,956,250 | 44,000,000 | ||
| Total | 64,780,363 | 56,413,014 | 47,000,000 | 50,000,000 |
The Group's bank loans concern loans for working capital and Bond Loans.
During the first half of 2021, the remaining 10 mil. Euros amount from the initial 20mil. Euro loan which was granted by Eurobank S.A. to GR. SARANTIS S.A, was fully repaid.
Moreover, during the 1st half year of 2021 a loan amounting to 10mil. Euros was granted to GR SARANTIS S.A by EBRD.
Furthermore, an investment loan amounting to 6.6mil. Euros was granted by BNP PARIBAS to POLIPAK.
| Group | Company | |||||
|---|---|---|---|---|---|---|
| 01.01-30.06.2021 | 01.01-30.06.2020 | 01.01-30.06.2021 | 01.01-30.06.2020 | |||
| Income tax | (5,551,973) | (5,165,571) | (807,370) | (947,812) | ||
| Deferred tax | 596,426 | 1,525,993 | (402,286) | 368,823 | ||
| Total | (4,955,546) | (3,639,578) | (1,209,656) | (578,989) |
With regard to the fiscal year 2020, the Company is subject to the tax audit of the Certified Auditors stipulated by the provisions of article 65A of Law 4174/2013. The audit is under progress and the relevant tax certificate is expected to be granted after the release of the semi-annual financial statements for the period 01.01-30.06.2021. The Management of the Company does not expect the emergence of any significant tax obligations apart from those already depicted in the financial statements.
Additionally, the Company's tax rate, according to no. 58 L.4172 / 2013, as amended by article 120 of law 4799/2021 (Government Gazette A '78 / 18-05-2021) and is in force, amounts to 22%.
The financial income / expenses are analyzed as follows:
| Group | 01.01 - 30.06.2021 01.01 - 30.06.2020 | |
|---|---|---|
| Interest Expense | (597,198) | (742,045) |
| Interest Income | 49,405 | 34,726 |
| Foreign exchange differences | (148,486) | (1,174,488) |
| Gain from sale of participations & securities | 366,487 | 147,177 |
| Loss from sale of participations & securities | (22,636) | (105,371) |
| Other financial income/expense | 162,397 | (800,220) |
| Total | (190,031) | (2,640,221) |
| Company | 01.01 - 30.06.2021 01.01 - 30.06.2020 | |
|---|---|---|
| Interest Expense | (558,834) | (632,038) |
| Interest Income | 15,292 | 59,545 |
| Foreign exchange differences | (15,127) | 37,912 |
| Gain from sale of participations & securities | 366,487 | 147,177 |
| Loss from sale of participations & securities | (22,636) | (105,371) |
| Dividends from subsidiaries | 16,278,150 | 7,216,165 |
| Other financial income/expense | 379,506 | (608,146) |
| Total | 16,442,837 | 6,115,244 |
| Share Capital | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Number of shares | Share premium | Total | |||||||||
| 30.06.2021 | 69,877,484 | 0.78 | 54,504,438 | 40,676,356 | 95,180,793 | ||||||
| 31.12.2020 | 69,877,484 | 0.78 | 54,504,438 | 40,676,356 | 95,180,793 | ||||||
| 31.12.2019 | 69,877,484 | 0.78 | 54,504,438 | 40,676,356 | 95,180,793 |
Earnings per share were calculated according to the weighted average number of shares after the deduction of the weighted average number of treasury shares held by the Company.
| Group | Company | |||||
|---|---|---|---|---|---|---|
| 01.01 - 30.06.2021 01.01 - 30.06.2020 01.01 - 30.06.2021 01.01 - 30.06.2020 | ||||||
| Earnings after tax attributed to the owners of the Company | 19,506,183 | 15,617,534 | 20,078,616 | 9,322,212 | ||
| Weighted average number of shares | 67,006,739 | 67,145,884 | 67,006,739 | 67,145,884 | ||
| Earnings per share (€ ) | 0.2912 | 0.2326 | 0.2997 | 0.1388 |
❖ For the period ended on 30/06/2021:
The Ordinary General Meeting of shareholders during its meeting on 20.05.2021 approved the distribution of a dividend of 0.214661421 Euros per share or a total amount of 15mil. Euros. According to the legislation in effect, the dividend that corresponded to 2,891,424 treasury shares of the Company increased the total dividend granted to other shareholders and therefore the total gross dividend per share accounted for 0.22392718 Euros.
The Ordinary General Meeting of shareholders during its meeting on 07.05.2020 approved the distribution of a dividend of 0.1604814 Euros per share or a total amount of 11,214,034 Euros. According to the legislation in effect, the dividend that corresponded to 2,731,600 treasury shares of the Company increased the total dividend granted to other shareholders and therefore the total gross dividend per share accounted for 0.16701 Euros.
During the first half of 2021, the Company proceeded to the purchase of 67,429 treasury shares at an average purchase price of 8.96 euro per share, paying 604,210 euro.
Including the 2,825,995 treasury shares already held by the company as of 31/12/2021, the Company holds in total 2,893,424 treasury shares with nominal value of EUR 0.78 per share and an average purchase price of 4.82 euro per share, having paid a total of 13,934,604 euro.
The treasury shares that the Company holds correspond to 4.14% of its share capital.
| Land - fields | Buildings, building facilities and technical projects |
Investment property | Machinery, technical installations and other equipment |
Vehicles | Furniture and other equipment |
Fixed assets under construction and prepayments |
Intangible assets | Total | |
|---|---|---|---|---|---|---|---|---|---|
| Acquisition cost 1.1.2020 | 8,550,833 | 35,712,545 | 31,972 | 16,794,644 | 1,048,714 | 12,286,365 | 134,992 | 29,129,726 | 103,689,791 |
| Acquisitions | 0 | 566,961 | 0 | 1,068,506 | 23,513 | 761,090 | 1,617,004 | 11,231,695 | 15,268,768 |
| Reclassifications | 0 | 36,733 | 0 | (4,564) | 0 | 4,746 | (111,610) | 74,696 | 0 |
| Revaluation | (245,218) | 684,942 | 0 | 0 | 0 | 0 | 0 | 0 | 439,724 |
| Write-offs | 0 | (326,932) | 0 | 0 | 0 | (889,161) | (18,510) | 0 | (1,234,603) |
| Cost of disposals | 0 | 0 | 0 | 0 | (31,620) | (6,319) | 0 | 0 | (37,939) |
| Value as at 31.12.2020 | 8,305,615 | 36,674,248 | 31,972 | 17,858,586 | 1,040,607 | 12,156,721 | 1,621,876 | 40,436,117 | 118,125,742 |
| Land - fields | Buildings, building facilities and technical projects |
Investment property | Machinery, technical installations and other equipment |
Vehicles | Furniture and other equipment |
Fixed assets under construction and prepayments |
Intangible assets | Total | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Depreciations 1.1.2020 | 0 | 16,978,390 | 115 | 9,790,071 | 812,248 | 8,583,725 | 0 | 7,469,897 | 43,634,448 | |
| Depreciations for the Period | 0 | 1,250,487 | 0 | 1,111,406 | 52,646 | 1,124,072 | 0 | 1,530,172 | 5,068,783 | |
| Revaluation | 0 | 404,562 | 0 | 0 | 0 | 0 | 0 | 0 | 404,562 | |
| Depreciation on write-offs | 0 | (326,837) | 0 | 0 | 0 | (876,687) | 0 | 0 | (1,203,524) | |
| Depreciation of disposals | 0 | 0 | 0 | 0 | (31,620) | (6,148) | 0 | 0 | (37,768) | |
| Depreciations 31.12.2020 | 0 | 18,306,603 | 115 | 10,901,477 | 833,274 | 8,824,961 | 0 | 9,000,069 | 47,866,501 | |
| Net book value as at 31.12.2020 | 8,305,615 | 18,367,645 | 31,857 | 6,957,109 | 207,333 | 3,331,759 | 1,621,876 | 31,436,048 | 70,259,241 |
| Land - fields | Buildings, building facilities and technical projects |
Investment property | Machinery, technical installations and other equipment |
Vehicles | Furniture and other equipment |
Fixed assets under construction and prepayments |
Intangible assets | Total | |
|---|---|---|---|---|---|---|---|---|---|
| Acquisition cost 1.1.2021 | 8,305,615 | 36,674,248 | 31,972 | 17,858,586 | 1,040,607 | 12,156,721 | 1,621,876 | 40,436,117 | 118,125,742 |
| Acquisitions | 0 | 48,753 | 0 | 1,427,988 | 28,469 | 422,964 | 1,993,491 | 28,243 | 3,949,908 |
| Reclassifications | 0 | 8,267 | 0 | 1,698,909 | 0 | 9,973 | (1,798,476) | 81,327 | 0 |
| Write-offs | 0 | 0 | 0 | 0 | 0 | (593,022) | 0 | 0 | (593,022) |
| Cost of disposals | 0 | 0 | 0 | 0 | (30,000) | (1,568) | 0 | 0 | (31,568) |
| Value as at 30.6.2021 | 8,305,615 | 36,731,268 | 31,972 | 20,985,483 | 1,039,076 | 11,995,068 | 1,816,891 | 40,545,687 | 121,451,061 |
| Land - fields | Buildings, building facilities and technical projects |
Investment property | Machinery, technical installations and other equipment |
Vehicles | Furniture and other equipment |
Fixed assets under construction and prepayments |
Intangible assets | Total | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Depreciations 1.1.2021 | 0 | 18,306,603 | 115 | 10,901,477 | 833,274 | 8,824,961 | 0 | 9,000,069 | 47,866,501 | |
| Depreciations for the Period | 0 | 643,024 | 0 | 600,993 | 25,389 | 473,728 | 0 | 786,730 | 2,529,865 | |
| Depreciation on write-offs | 0 | 0 | 0 | 0 | 0 | (589,855) | 0 | 0 | (589,855) | |
| Depreciation of disposals | 0 | 0 | 0 | 0 | (7,150) | (1,092) | 0 | 0 | (8,242) | |
| Depreciations 30.6.2021 | 0 | 18,949,627 | 115 | 11,502,470 | 851,513 | 8,707,743 | 0 | 9,786,800 | 49,798,269 | |
| Net book value as at 30.6.2021 | 8,305,615 | 17,781,641 | 31,857 | 9,483,013 | 187,563 | 3,287,325 | 1,816,891 | 30,758,887 | 71,652,792 |
The right of use assets for the Company as at 30 th June 2021 are as follows:
| Buildings, building facilities and technical projects |
Vehicles | Total | |
|---|---|---|---|
| Acquisition cost 1.1.2020 | 3,764,903 | 2,337,923 | 6,102,826 |
| Acquisitions | 2,745,829 | 133,924 | 2,879,753 |
| Write-offs | (352,608) | (77,188) | (429,796) |
| Value as at 31.12.2020 | 6,158,123 | 2,394,659 | 8,552,782 |
| Buildings, building facilities and technical projects |
Vehicles | Total | |
| Depreciations 1.1.2020 | 907,065 | 592,230 | 1,499,295 |
| Depreciations for the Period | 1,084,175 | 660,011 | 1,744,186 |
| Depreciation on write-offs | (328,494) | (56,469) | (384,963) |
| Depreciations 31.12.2020 | 1,662,745 | 1,195,773 | 2,858,518 |
| Net book value as at 31.12.2020 | 4,495,378 | 1,198,886 | 5,694,264 |
| Buildings, building facilities and technical projects |
Vehicles | Total | |
|---|---|---|---|
| Acquisition cost 1.1.2021 | 6,158,123 | 2,394,659 | 8,552,782 |
| Acquisitions | 3,022 | 59,827 | 62,848 |
| Write-offs | (159,893) | (55,232) | (215,125) |
| Value as at 30.6.2021 | 6,001,252 | 2,399,253 | 8,400,505 |
| Buildings, building facilities and technical projects |
Vehicles | Total | |
|---|---|---|---|
| Depreciations 1.1.2021 | 1,662,745 | 1,195,773 | 2,858,518 |
| Depreciations for the Period | 550,091 | 334,168 | 884,259 |
| Depreciation on write-offs | (159,893) | (32,675) | (192,568) |
| Depreciations 30.6.2021 | 2,052,942 | 1,497,266 | 3,550,208 |
| Net book value as at 30.6.2021 | 3,948,310 | 901,988 | 4,850,297 |
| Land - fields | Buildings, building facilities and technical projects |
Investment property |
Machinery, technical installations and |
Vehicles | Furniture and other equipment |
Fixed assets under construction and prepayments |
Intangible assets | Total | |
|---|---|---|---|---|---|---|---|---|---|
| Acquisition cost 1.1.2020 | 11,116,955 | 49,249,832 | 1,032,727 | 41,314,472 | 2,693,227 | 13,532,516 | 1,708,456 | 64,741,919 | 185,390,104 |
| Acquisitions | 17,531 | 635,294 | 0 | 1,891,008 | 124,102 | 903,794 | 12,366,606 | 11,765,973 | 27,704,309 |
| Reclassifications | 0 | 36,568 | 0 | 1,340,369 | 36,976 | (180,864) | (1,307,744) | 74,696 | 0 |
| Revaluation | (234,245) | 1,355,177 | 19,057 | 0 | 0 | 0 | 0 | 0 | 1,139,988 |
| Write-offs | 0 | (326,932) | 0 | (111,828) | (53,220) | (889,401) | (127,481) | (13,809) | (1,522,672) |
| Cost of disposals | 0 | 0 | 0 | (906,835) | (139,801) | (57,415) | 0 | (123) | (1,104,174) |
| Foreign exchange differences | (216,566) | (1,893,541) | (18,643) | (3,102,743) | (118,709) | (96,605) | (597,800) | (1,014,818) | (7,059,424) |
| Value as at 31.12.2020 | 10,683,675 | 49,056,398 | 1,033,141 | 40,424,444 | 2,542,574 | 13,212,025 | 12,042,037 | 75,553,838 | 204,548,131 |
| Land - fields | Buildings, building facilities and technical projects |
Investment property |
Machinery, technical installations and |
Vehicles | Furniture and other equipment |
Fixed assets under construction and prepayments |
Intangible assets | Total | |
|---|---|---|---|---|---|---|---|---|---|
| Depreciations 1.1.2020 | 0 20,440,850 |
115 | 20,755,885 | 1,905,221 | 9,297,502 | 0 | 13,052,237 | 65,451,811 | |
| Depreciations for the Period | 0 1,560,074 |
0 | 2,925,252 | 196,628 | 1,213,043 | 0 | 2,381,423 | 8,276,420 | |
| Revaluation | 0 610,196 |
0 | 0 | 0 | 0 | 0 | 0 | 610,196 | |
| Depreciations of reclassifications | 0 (4,462) |
0 | 126,253 | 33,698 | (155,488) | 0 | 0 | 0 | |
| Depreciation on write-offs | 0 (326,837) |
0 | (96,824) | (39,386) | (876,873) | 0 | (13,809) | (1,353,728) | |
| Depreciation of disposals | 0 0 |
0 | (632,837) | (126,806) | (38,590) | 0 | (123) | (798,356) | |
| Foreign exchange differences | 0 (620,554) |
0 | (1,385,107) | (81,633) | (61,066) | 0 | (247,211) | (2,395,571) | |
| Depreciations 31.12.2020 | 0 21,659,267 |
115 | 21,692,623 | 1,887,722 | 9,378,528 | 0 | 15,172,516 | 69,790,772 | |
| Net book value as at 31.12.2020 | 10,683,675 | 27,397,130 | 1,033,026 | 18,731,821 | 654,852 | 3,833,496 | 12,042,037 | 60,381,322 | 134,757,359 |
| Land - fields | Buildings, building facilities and technical projects |
Investment property |
Machinery, technical installations and |
Vehicles | Furniture and other equipment |
Fixed assets under construction and prepayments |
Intangible assets | Total | |
|---|---|---|---|---|---|---|---|---|---|
| Acquisition cost 1.1.2021 | 10,683,675 | 49,056,398 | 1,033,141 | 40,424,444 | 2,542,574 | 13,212,025 | 12,042,037 | 75,553,838 | 204,548,131 |
| Acquisitions | 7,197 | 48,753 | 0 | 1,756,445 | 65,069 | 445,723 | 13,683,484 | 46,281 | 16,052,951 |
| Reclassifications | 0 | 301,437 | 0 | 1,764,255 | 71,503 | 10,591 | (2,229,113) | 81,327 | 0 |
| Write-offs | 0 | 0 | 0 | (19,361) | (37,217) | (595,870) | (81,416) | (53,169) | (787,033) |
| Cost of disposals | 0 | 0 | 0 | (12,885) | (50,003) | (4,680) | 0 | 0 | (67,567) |
| Foreign exchange differences | 53,989 | 481,524 | (11,644) | 786,473 | 31,509 | 15,294 | 272,994 | 468,211 | 2,098,351 |
| Value as at 30.6.2021 | 10,744,860 | 49,888,111 | 1,021,497 | 44,699,371 | 2,623,436 | 13,083,083 | 23,687,987 | 76,096,488 | 221,844,832 |
| Land - fields | Buildings, building facilities and technical projects |
Investment property |
Machinery, technical installations and |
Vehicles | Furniture and other equipment |
Fixed assets under construction and prepayments |
Intangible assets | Total | |
|---|---|---|---|---|---|---|---|---|---|
| Depreciations 1.1.2021 | 0 21,659,267 |
115 | 21,692,623 | 1,887,722 | 9,378,528 | 0 | 15,172,516 | 69,790,772 | |
| Depreciations for the Period | 0 803,158 |
0 | 1,505,201 | 92,717 | 518,436 | 0 | 1,219,467 | 4,138,979 | |
| Depreciation on write-offs | 0 0 |
0 | (15,769) | (26,602) | (592,703) | 0 | (53,169) | (688,242) | |
| Depreciation of disposals | 0 0 |
0 | (8,727) | (27,153) | (3,210) | 0 | 0 | (39,089) | |
| Foreign exchange differences | 0 158,592 |
0 | 376,412 | 21,068 | 8,780 | 0 | 74,258 | 639,111 | |
| Depreciations 30.6.2021 | 0 22,621,017 |
115 | 23,549,740 | 1,947,753 | 9,309,831 | 0 | 16,413,073 | 73,841,530 | |
| Net book value as at 30.6.2021 | 10,744,860 | 27,267,094 | 1,021,382 | 21,149,630 | 675,683 | 3,773,251 | 23,687,987 | 59,683,415 | 148,003,302 |
The increase in "Fixed Assets under construction and prepayments" during the first half of 2021 is mainly due to the project in progress at Polipak, which is expected to be complete within 2022.
The net book value of the Group's intangible assets as at 30/06/2021 consists of trademarks - rights amounting to approximately 53.3 million euros (53.9 million euros on 31/12/2020) and software programs amounting to approximately 6.3 million euros (6.5 million euroson 31/12/2020).
Respectively, the net book value of the Company's intangible assets as at 30/06/2021 consists of trademarks - rights amounting to approximately 27.2 million euros (27.7 million euros on 31/12/2020) and software programs amounting to approximately EUR 3.6 million (EUR 3.7 million on 31/12/2020).
The right of use assets for the Group as at 30 th June 2021 are as follows:
| Land - fields | Buildings, building facilities and technical projects |
Machinery, technical installations and other equipment |
Vehicles | Furniture and other equipment |
Total | |
|---|---|---|---|---|---|---|
| Acquisition cost 1.1.2020 | 295,575 | 11,037,268 | 21,685 | 4,163,235 | 94,034 | 15,611,797 |
| Acquisitions | 0 | 4,768,275 | 0 | 2,817,440 | 0 | 7,585,715 |
| Write-offs | (1,063) | (421,778) | (20,776) | (636,979) | 0 | (1,080,597) |
| Foreign exchange differences | (70,648) | (413,052) | (909) | (77,130) | (1,740) | (563,479) |
| Value as at 31.12.2020 | 223,864 | 14,970,713 | 0 | 6,266,566 | 92,294 | 21,553,436 |
| Land - fields | Buildings, building facilities and technical projects |
Machinery, technical installations and other equipment |
Vehicles | Furniture and other equipment |
Total | |
|---|---|---|---|---|---|---|
| Depreciations 1.1.2020 | 10,714 | 2,398,205 | 8,674 | 1,221,642 | 12,393 | 3,651,628 |
| Depreciations for the Period | 9,142 | 2,780,764 | 5,540 | 1,559,951 | 13,298 | 4,368,696 |
| Depreciation on write-offs | 0 | (360,140) | (13,851) | (579,337) | 0 | (953,328) |
| Foreign exchange differences | (3,602) | (116,142) | (364) | (15,822) | (317) | (136,246) |
| Depreciations 31.12.2020 | 16,255 | 4,702,688 | 0 | 2,186,434 | 25,375 | 6,930,751 |
| Net book value as at 31.12.2020 | 207,609 | 10,268,025 | 0 | 4,080,132 | 66,919 | 14,622,686 |
| Land - fields | Buildings, building facilities and technical projects |
Machinery, technical installations and other equipment |
Vehicles | Furniture and other equipment |
Total | |
|---|---|---|---|---|---|---|
| Acquisition cost 1.1.2021 | 223,864 | 14,970,713 | 0 | 6,266,566 | 92,294 | 21,553,436 |
| Acquisitions | 0 | 64,492 | 0 | 215,641 | 0 | 280,133 |
| Write-offs | 0 | (282,913) | 0 | (141,162) | 0 | (424,075) |
| Foreign exchange differences | 16,895 | 90,340 | 0 | 30,330 | (1,073) | 136,491 |
| Value as at 30.6.2021 | 240,759 | 14,842,632 | 0 | 6,371,375 | 91,220 | 21,545,986 |
| Land - fields | Buildings, building facilities and technical projects |
Machinery, technical installations and other equipment |
Vehicles | Furniture and other equipment |
Total | |
|---|---|---|---|---|---|---|
| Depreciations 1.1.2021 | 16,255 | 4,702,688 | 0 | 2,186,434 | 25,375 | 6,930,751 |
| Depreciations for the Period | 4,199 | 1,422,541 | 0 | 861,024 | 6,491 | 2,294,255 |
| Depreciation on write-offs | 0 | (207,939) | 0 | (92,357) | 0 | (300,296) |
| Foreign exchange differences | 1,382 | 37,273 | 0 | 7,133 | (329) | 45,458 |
| Depreciations 30.6.2021 | 21,836 | 5,954,562 | 0 | 2,962,233 | 31,537 | 8,970,167 |
| Net book value as at 30.6.2021 | 218,923 | 8,888,070 | 0 | 3,409,141 | 59,684 | 12,575,819 |
| Group | Company | |||||
|---|---|---|---|---|---|---|
| 01.01 - 30.06.2021 01.01 - 30.06.2020 01.01 - 30.06.2021 01.01 - 30.06.2020 | ||||||
| Regular employees | 2,186 | 2,215 | 770 | 789 | ||
| Day-wage employees | 352 | 557 | 9 0 |
9 5 |
||
| Total Employees | 2,538 | 2,772 | 860 | 884 |
The number of employees for the Group and Company is as follows:
There are no pending or under arbitration legal cases and decisions by judicial or arbitration bodies which may significantly affect the financial statements of the Group and the Company, apart from the case of Marinopoulos S.A., where the Company has a claim of 2.4 million euros, that is included in the Company's provisions.
During the period 01.01 – 30.06.2021 there are no contingent liabilities either in the Group or the Company.
The Company has guaranteed loan liabilities of its subsidiaries.
A new investment in the subsidiary company Polipak is in progress that will lead to a more automated production process. The cost of this project for the following years and until it is completed is estimated at approximately € 25 million.
The Group announced on July 8th 2021 that, in accordance with the terms and conditions of the amended Shareholders Agreement entered into with Estee Lauder Europe, Inc. ("EL Europe") with respect to the company ELCA Cosmetics Limited ("ELCA"), EL Europe provided the first call option notice for the purchase of shares held by the Group. The first call option represents 9% of ELCA's shares.
ELCA is a joint venture that was created in 2001 for the sale and distribution of beauty products in Greece, Romania, Bulgaria and Cyprus. ELCA is currently owned by Sarantis Group, which holds a 49% interest in the joint venture and EL Europe which holds the remaining 51% interest.
ELCA is based in Cyprus and fully owns the subsidiary companies ESTEE LAUDER HELLAS S.A. Cosmetics Distribution, ΕSTEE LAUDER BULGARIA EOOD and ESTEE LAUDER ROMANIA Srl., based in Greece, Bulgaria and Romania respectively.
Based on the amended Shareholders Agreement, EL Europe has the right to increase its interest in ELCA to 100% by purchasing shares held by the Group, including the right to increase its stake based on the financial statements of ELCA at June 30th 2021, June 30th 2024 and June 30th 2027 for 9%, 25% and 15% respectively.
The Group's strategy with respect to ELCA remains unchanged and is based on two factors:
1) utilizing the liquidity that will be created during the period 2021-2027 behind acquisitions that satisfy the Group's criteria and are able to provide synergies and contribute to profitability; 2) absorbing new distribution agreements that will further strengthen the Group's product portfolio.
As always, the management's goal is to execute its investment plan, focusing on its strategic product categories, geographical expansion and cost efficiencies, ultimately creating further value to its shareholders.
❖ During July 16th 2021, the Extraordinary General Shareholders' Meeting of "GR. SARANTIS S.A." took place, with the sole item on the agenda being the approval of the Suitability Policy for the BoD members according to article 3. paragraph 3 of the law 4706/2020.
Read the resolutions of the Extraordinary General Shareholders Meeting of July 16th 2021.
The most significant transactions between the Company and its related parties, as such are defined by International Accounting Standard 24, are presented below.
| Company Subsidiaries |
|||
|---|---|---|---|
| Trade receivables | 30.06.2021 | 31.12.2020 | |
| Sarantis Belgrade D.O.O | 39,750 | 88,281 | |
| Sarantis Banja Luca DOO | 0 | 197 | |
| Sarantis Skopje D.O.O | 0 | 245 | |
| Sarantis Bulgaria LTD | 157,023 | 153,617 | |
| Sarantis Romania S.A. | 799,271 | 582,200 | |
| Sarantis Polska S.A. | 884,047 | 723,296 | |
| Sarantis Czech Republic sro | 1,297,134 | 1,422,939 | |
| Polipak SP.Z.O.O. | 6,414 | 47,530 | |
| Sarantis Slovakia S.R.O | 156,089 | 320,150 | |
| Ergopack LLC | 1,092,792 | 1,108,875 | |
| Sarantis Hungary Kft. | 113,218 | 303,954 | |
| Sarantis Portugal Lda | 595,831 | 1,119,722 | |
| Elode France SARL | 28,480 | 27,734 | |
| Total | 5,170,050 | 5,898,740 |
| Trade Liabilities | 30.06.2021 | 31.12.2020 |
|---|---|---|
| Sarantis Belgrade D.O.O | 2,020,204 | 1,067,589 |
| Sarantis Banja Luca DOO | 4,251 | 5,648 |
| Sarantis Skopje D.O.O | 1,033,479 | 301,140 |
| Sarantis Bulgaria LTD | 17,108 | 0 |
| Sarantis Romania S.A. | 80,748 | 10,687 |
| Sarantis Polska S.A. | 425,791 | 629,875 |
| Sarantis Czech Republic sro | 18,525 | 0 |
| Polipak SP.Z.O.O. | 753,921 | 321,052 |
| Sarantis Slovakia S.R.O | 4,252 | 0 |
| Ergopack LLC | 61,699 | 470 |
| Sarantis Hungary Kft. | 11,532 | 10,626 |
| Sarantis Portugal Lda | 744 | 0 |
| Sarantis France SARL | 48,200 | 48,960 |
| Total | 4,480,454 | 2,396,047 |
| Liabilities from loans | 30.06.2021 | 31.12.2020 |
| Liabilities from loans | 30.06.2021 | 31.12.2020 |
|---|---|---|
| Sarantis Bulgaria LTD | 6,751,855 | 7,501,237 |
| Sarantis Romania S.A. | 13,503,711 | 15,002,474 |
| Sarantis Polska S.A. | 6,751,855 | 7,501,237 |
| Waldeck LTD | 559,194 | 558,255 |
| Total | 27,566,616 | 30,563,203 |
| Grand Total Liabilities | 32,047,069 | 32,959,250 |
| Income from sale of merchandise | 01.01 - 30.06.2021 | 01.01 - 30.06.2020 |
|---|---|---|
| Sarantis Belgrade D.O.O | 1,004,745 | 1,353,981 |
| Sarantis Skopje D.O.O | 267,476 | 358,324 |
| Sarantis Bulgaria LTD | 845,471 | 968,681 |
| Sarantis Romania S.A. | 2,883,377 | 3,645,733 |
| Sarantis Polska S.A. | 3,927,582 | 3,904,976 |
| Sarantis Czech Republic sro | 2,279,745 | 1,658,030 |
| Sarantis Slovakia S.R.O | 929,323 | 428,420 |
| Ergopack LLC | 529,042 | 662,119 |
| Sarantis Hungary Kft. | 244,492 | 331,088 |
| Sarantis Portugal Lda | 355,733 | 387,868 |
| Total | 13,266,985 | 13,699,221 |
| Income – Interest | 01.01 - 30.06.2021 | 01.01 - 30.06.2020 |
| Ergopack LLC | 0 | 53,849 |
| Total | 0 | 53,849 |
| Other Income | 01.01 - 30.06.2021 | 01.01 - 30.06.2020 |
|---|---|---|
| Sarantis Belgrade D.O.O | 88,953 | 99,059 |
| Sarantis Banja Luca DOO | 4,251 | 2,249 |
| Sarantis Skopje D.O.O | 10,772 | 9,018 |
| Sarantis Bulgaria LTD | 17,481 | 11,727 |
| Sarantis Romania S.A. | 41,791 | 41,038 |
| Sarantis Polska S.A. | 264,445 | 122,452 |
| Sarantis Czech Republic sro | 74,123 | 38,905 |
| Polipak SP.Z.O.O. | 30,716 | 14,345 |
| Sarantis Slovakia S.R.O | 31,406 | 13,938 |
| Ergopack LLC | 78,581 | 120,705 |
| Sarantis Hungary Kft. | 31,727 | 39,188 |
| Sarantis Portugal Lda | 27,081 | 32,609 |
| Total | 701,328 | 545,234 |
| Grand Total Income | 13,968,314 | 14,298,303 |
| Purchases of Merchandise - Services | 01.01 - 30.06.2021 | 01.01 - 30.06.2020 |
|---|---|---|
| Sarantis Belgrade D.O.O | 0 | 6,938 |
| Sarantis Romania S.A. | 49,732 | 7,355 |
| Sarantis Polska S.A. | 868,115 | 877,614 |
| Sarantis Czech Republic sro | 399 | 6,829 |
| Polipak SP.Z.O.O. | 1,491,492 | 2,056,495 |
| Sarantis Slovakia S.R.O | 1,424 | 0 |
| Ergopack LLC | 0 | 2,736 |
| Total | 2,411,162 | 2,957,967 |
| Expenses – Interest | 01.01 - 30.06.2021 | 01.01 - 30.06.2020 |
| Sarantis Bulgaria LTD | 70,626 | 93,844 |
| Sarantis Romania S.A. | 141,251 | 188,006 |
| Sarantis Polska S.A. | 70,626 | 94,279 |
| Waldeck LTD | 10,939 | 11,000 |
| Total | 293,441 | 387,128 |
| Grand Total Expenses | 2,704,603 | 3,345,094 |
| Table of Disclosures of Related Parties | ||||
|---|---|---|---|---|
| Group Company |
||||
| a) Income | 0 | 13,968,314 | ||
| b) Expenses | 0 | 2,704,603 | ||
| c) Receivables | 0 | 5,170,050 | ||
| d) Liabilities | 0 | 32,047,069 | ||
| e) Transactions and remuneration of senior executives and management | 1,686,693 | 1,686,693 | ||
| f) Receivables from senior executives and management | 84,778 | 84,778 | ||
| g) Liabilities towards senior executives and management | 0 | 0 | ||
| h) Receivables from affiliates | 178 | 178 | ||
| i) Liabilities to affiliates | 0 | 0 |
It is noted that related party transactions are done at market purchase prices.
| SBU Turnover (€ mil) | H1 '21 | % | H1 '20 |
|---|---|---|---|
| Personal Care | 85.09 | 8.02% | 78.77 |
| % of Total | 43.58% | 42.88% | |
| Own | 55.80 | 12.22% | 49.72 |
| % of SBU | 65.58% | 63.12% | |
| Distributed | 29.29 | 0.83% | 29.05 |
| % of SBU | 34.42% | 36.88% | |
| Home Care | 76.13 | 6.22% | 71.67 |
| % of Total | 38.99% | 39.02% | |
| Own | 74.92 | 5.29% | 71.15 |
| % of SBU | 98.41% | 99.28% | |
| Distributed | 1.21 | 134.54% | 0.52 |
| % of SBU | 1.59% | 0.72% | |
| Private Label | 11.45 | 5.33% | 10.87 |
| % of Total | 5.87% | 5.92% | |
| Other Sales | 22.57 | 0.84% | 22.38 |
| % of Total | 11.56% | 12.18% | |
| Health Care | 4.31 | -8.33% | 4.70 |
| % of SBU | 19.11% | 21.02% | |
| Luxury Cosmetics | 18.25 | 3.28% | 17.67 |
| % of SBU | 80.89% | 78.98% | |
| Total Turnover | 195.24 | 6.29% | 183.69 |
| SBU EBIT (€ mil) | H1 '21 | % | H1 '20 | |
|---|---|---|---|---|
| Personal Care | 5.85 | 15.92% | 5.05 | |
| Margin | 6.88% | 6.41% | ||
| % of EBIT | 23.49% | 22.68% | ||
| Own | 5.52 | 22.84% | 4.50 | |
| Margin | 9.90% | 9.04% | ||
| % of EBIT | 22.18% | 20.20% | ||
| Distributed | 0.33 | -40.59% | 0.55 | |
| Margin | 1.12% | 1.90% | ||
| % of EBIT | 1.31% | 2.48% | ||
| Home Care | 9.56 | 12.20% | 8.52 | |
| Margin | 12.56% | 11.89% | ||
| % of EBIT | 38.41% | 38.30% | ||
| Own | 9.46 | 11.50% | 8.48 | |
| Margin | 12.63% | 11.92% | ||
| % of EBIT | 37.99% | 38.12% | ||
| Distributed | 0.10 | 160.01% | 0.04 | |
| Margin | 8.54% | 7.70% | ||
| % of EBIT | 0.42% | 0.18% | ||
| Private Label | 1.10 | -28.41% | 1.54 | |
| Margin | 9.62% | 14.16% | ||
| % of EBIT | 4.43% | 6.92% | ||
| Other Sales | 2.04 | 2.03% | 2.00 | |
| Margin | 9.03% | 8.92% | ||
| % of EBIT | 8.18% | 8.97% | ||
| Health Care | 0.52 | -31.59% | 0.76 | |
| Margin | 12.09% | 16.20% | ||
| % of EBIT | 2.09% | 3.42% | ||
| Luxury Cosmetics | 1.52 | 22.78% | 1.23 | |
| Margin | 8.30% | 6.98% | ||
| % of EBIT | 6.09% | 5.55% | ||
| Income from Associated Companies | 6.35 | 23.25% | 5.15 | |
| % of EBIT | 25.49% | 23.14% | ||
| Total EBIT | 24.90 | 11.88% | 22.26 | |
| Margin | 12.75% | 12.12% |
| Country Turnover (€ mil) | H1 '21 | % | H1 '20 |
|---|---|---|---|
| Greece | 69.25 | 2.38% | 67.64 |
| % of Total Turnover | 35.47% | 36.82% | |
| Poland | 35.36 | 11.96% | 31.58 |
| Poland - Polipak | 11.45 | 5.33% | 10.87 |
| Romania | 27.56 | 13.79% | 24.22 |
| Bulgaria | 6.13 | 18.86% | 5.16 |
| Serbia | 9.12 | 2.57% | 8.89 |
| Czech Republic | 11.03 | 15.37% | 9.56 |
| Slovakia | 2.95 | 0.49% | 2.94 |
| Hungary | 4.50 | 0.00% | 4.50 |
| North Macedonia | 2.03 | 5.45% | 1.93 |
| Bosnia | 1.57 | 18.97% | 1.32 |
| Portugal | 0.73 | 17.56% | 0.62 |
| Ukraine | 12.60 | -5.54% | 13.34 |
| Russia | 0.97 | -14.96% | 1.14 |
| Foreign Countries Subtotal | 125.99 | 8.56% | 116.05 |
| % of Total Turnover | 64.53% | 63.18% | |
| Total Turnover | 195.24 | 6.29% | 183.69 |
| Country ΕΒΙΤ (€ mil) | H1 '21 | % | H1 '20 |
|---|---|---|---|
| Greece | 15.49 | 19.27% | 12.99 |
| % of Total Ebit | 62.20% | 58.34% | |
| Poland | 3.43 | 0.24% | 3.43 |
| Poland-Polipak | 1.10 | -28.41% | 1.54 |
| Romania | 2.82 | 27.00% | 2.22 |
| Bulgaria | 0.19 | -44.84% | 0.35 |
| Serbia | 0.37 | -32.45% | 0.55 |
| Czech Republic | 1.17 | 82.35% | 0.64 |
| Slovakia | 0.24 | 6884.70% | 0.00 |
| Hungary | 0.05 | 529.66% | 0.01 |
| North Macedonia | 0.21 | -9.14% | 0.23 |
| Bosnia | -0.11 | -102.41% | -0.05 |
| Portugal | -0.07 | 48.47% | -0.13 |
| Ukraine | 0.02 | -96.55% | 0.46 |
| Russia | -0.01 | 157.14% | 0.02 |
| Foreign Countries Subtotal | 9.41 | 1.52% | 9.27 |
| % of Total Ebit | 37.80% | 41.66% | |
| Total EBIT | 24.90 | 11.88% | 22.26 |
Marousi, September 8th 2021
| THE CHAIRMAN OF THE BOARD |
MANAGING DIRECTOR |
THE GROUP'S CHIEF FINANCIAL OFFICER & BOARD MEMBER |
THE COMPANY'S FINANCE DIRECTOR |
THE ACCOUNTANT DIRECTOR |
|---|---|---|---|---|
| GRIGORIS SARANTIS | KYRIAKOS SARANTIS | KONSTANTINOS ROZAKEAS | ANASTASIA STAVROULA LATSOU |
EFSTATHIOS STEFAS |
| ID No. Χ 080619/03 | ID No. ΑΙ 597050/2010 |
ID No. ΑΚ 783631/13 | ID No. ΑΑ 128208/05 | ID No. ΑI 988547/12 |
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.